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Abstract
The neurotrophins are a family of secreted proteins that potently regulate diverse
neuronal responses. Family members include nerve growth factor (NGF), brain-derived
neurotrophic factor (BDNF), neurotrophin-3 (NT-3) and neurotrophin 4/5(NT4/5).
Neurotrophins bind the Trks receptor family (TrkA, B, C). NGF is the preferred ligand
for TrkA, BDNF and NT4/5 are preferred for TrkB, and NT3 for TrkC, although NT3
also binds with less affinity to TrkA and TrkB.
During my PhD I have focused my interest in understanding how neurotrophins regulate
gene expression and, in particular, how BDNF does this through its high affinity receptor
TrkB during neurogenesis. In order to answer this question, I planned to adopt the
following approaches. First, to analyze global changes in gene expression after
TrkB/BDNF activation, using microarray technology. Second, once a set of regulated
genes was identified, to characterize the regulation of these genes at the promoter level,
in order to understand which common elements are important for their regulation.
The high-density oligonucleotide array of Affymetrix was performed using mRNAs that
were obtained from cortical neurons of wild type mouse embryos (E15.5), and of mouse
embryos possessing TrkB receptors mutated at either tyrosine 515 (trkB/shc point
signaling mutants), or tyrosine 816 (trkB/plc-g point signaling mutants), or at both sites.
In all cases the primary neurons were either unstimulated or stimulated with BDNF. The
sensitivity of the Affymetrix system allowed me to identify a set of transcription factors
that showed a higher fold induction compared to the others class of genes. This group
consisted of: egr1, egr2, c-fos and mGIF/Tieg1. These genes were found to be
differentially regulated in the signaling point mutant mice. Although the promoter of
mGif/TIEG1 is not yet characterized and also the function of this gene is not completely
clear, egr1, egr2 and c-fos are well characterized, and, several data suggest that these
genes share cis acting 5’ regulatory elements. To better understand which elements and
transcription factors are important for BDNF-dependent gene expression I choose the c-
fos promoter as a model. Using luciferase reporter gene constructs transfected in E15.5
cortical neurons isolated from wild-type and signaling point mutant mice, I discovered
that the pathways activated through the shc site promoted higher activation of c-fos
promoter than pathways activated through the plc-g site, and the two sites are both
required for BDNF-dependent activation of c-fos promoter. Additionally experiments
using c-fos promoter constructs, mutated at single or multiple elements, revealed that the
c/ebp binding site together with the E-box are fundamental for the activation of c-fos
downstream BDNF/TrkB. This result suggested that C/EBPs and bHLH transcription
factors might collaborate to induce the activation of the promoter downstream of BDNF.
I have demonstrated, both in vivo and in vitro, that Mash1 and NeuroD are the members
of bHLH family that bind C/EBP transcription factors at different domains. That
interaction is BDNF independent, and the complex is constitutively present on the c-fos
promoter. The BDNF regulation of gene expression is through the post-translation
modification of that complex.  In fact BDNF stimulation induces an increase in C/EBPb
phosphorylation on Thr188 (ERK1/2-dependent). The phosphorylation by ERK1/2 could
explain the transcriptional activation of the C/EBP-Mash1-NeuroD complex downstream
BDNF/TrkB. These studies identify a novel neurotrophins-regulated signaling cascade
that mediates the gene expression during neurogenesis.
11
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The diverse functions of the vertebrate nervous system, which range from sensory
perception and motor coordination to motivation and memory, depend on precise
connections formed between distinct types of nerve cells. The formation of these cell
types and the connections are made between them occur during embryonic and postnatal
development.
During the past decade there have been many striking advances in our understanding of
the molecular basis of neuronal development. These advances include the identification
of proteins that determine how nerve cells acquire their identities, extend axons to target
cells, and form synaptic connections, and have provided insight into how synaptic
connections are modified by experience.
It is clear that development of the mammalian nervous system is determined by a
complex interplay between intrinsic genetic mechanism and extrinsic cues such as growth
factors. Within the central nervous system, this interplay has perhaps been best studied in
the developing cortex.
After a brief introduction about the development of the entire nervous system, we focus
specifically on the development of the cortex, and on three classes of molecules that play
a role in this process: bHLH transcription factors, C/EBP transcription factors and
neurotrophins. I will also describe the c-fos promoter that I used as a model to understand
the regulation of gene expression downstream BDNF/TrkB, and the mGif/TIEG1
transcription factor, that we discovered to be downstream BDNF/TrkB signaling.
1.1 The nervous system arises from the ectoderm
The nervous system begins to develop at a relatively late stage in embryogenesis. Prior to
its formation, three main cell layers have been generated. The endoderm, the innermost
layer, give rise to the gut, esophagous, stomach, pancreas, lungs, and liver; the
mesoderm, the middle layer, give rise to blood, adipose tissue, connective tissue, muscle,
and the vascular system; and the ectoderm, the outermost layer, give rise to the major
tissue of the central and peripheral nervous systems (Kandel et al.).
Ectodermal cells form a sheet along the dorsal midline of the embryo at the gastrula
stage. As this ectodermal sheet begins to acquire neural properties it forms the neural
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tube, a columnar epithelium. Ectodermal cells that fail to follow the neural program of
differentiation give rise instead to the epidermis of the skin.
Soon after the neural tube has formed it begins to fold into a tubular structure through a
process called neurulation. The caudal region of the neural tube gives rise to the spinal
cord, and the rostral region becomes the brain.
During these early stages cell proliferation is not uniform along the length of the neural
tube, and as a result, specialized regions of the mature central nervous system begin to
form. The proliferation of cells in the rostral part of the neural tube initially forms three
brain vesicles: the forebrain (or prosencephalon), the midbrain (or mesencephalon), and
the hindbrain (or rhombencephalon). Later in development, two of the three primary
embryonic vesicles subdivide (table1). The forebrain vesicle gives rise to the
telencephalon and diencephalon, and the hindbrain vesicle gives rise to the
metencephalon and myelencephalon. These subdivisions, together with the spinal cord,
comprise the six regions of the mature nervous system.
Table 1 The main subdivisions of the embryonic central nervous system and mature adult
forms(Kandel, Schwartz et al.)
Three-vesicle stage Five-vesicle stage Major mature derivatives
1. Forebrain 1a.Telencephalon 1.cerebral cortex, basal
ganglia, hippocampus,
amygdala, olfactory bulb
1b.Diencephalon 2.Thalamus, hypothalamus,
subthalamus, epithalamus,
retina, optic nerves and
tracts
2. Midbrain 2. Mesencephalon 3.Midbrain
3. Hindbrain 3a.Metencephalon 4.pons and cerebellum
3b.Myelencephalon 5.Medulla
4.Cadual part of neural tube 4.Cadual part of neural tube 6. Spinal cord
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1.2 Cortical development
The telencephalon is subdivided into the ventral telencephalon, which develops into basal
ganglia, and the dorsal telencephalon, which gives rise to the hippocampus, the olfactory
cortex, and the neocortex (Marin and Rubenstein, 2001; Parnavelas, 2000)(figure1).
The neocortex is generated from neural stem cells of the CNS. These cells are defined by
their ability to self-renew, and have the potential to become neurons, astrocytes, and
oligodendrocytes.
During development of the neocortex, positional information is helping to specify the cell
fate of progenitor cells. Once a progenitor goes through its final round of cell division, it
begins to differentiate while simultaneously migrating from the ventricular zone to its
final destination. Differentiation of neural precursor into neurons, astrocytes, and
oligodentrocytes takes place in overlapping, but temporally distinct waves, giving rise
sequentially to the neurogenic phase, the astroglial phase, and the oligodendroglial phase
(Sauvageot and Stiles, 2002). Neuronal differentiation in the mammalian neocortex peaks
approximately two-thirds of the way through gestation, corresponding E15.5 in the
mouse. Astrocyte differentiation occurs next, peaking at birth. Oligodendrocyte
differentiation follows later still, occurring during the first month of murine life.
Neuronal migration in the cerebral cortex begins when the first cohort of postmitotic
neurons leaves the germinal zone (VZ) to form the primordial plexiform layer, or
preplate, at the surface of the cerebral vesicles (figure2A-C) (Nadarajah and Parnavelas,
2002). This early-generated zone is then split by the arrival of accumulating cortical plate
(CP) neurons into the superficial marginal zone (MZ) and the deeper subplate. Layers II-
VI of the cerebral cortex are generated in an “inside-out” sequence (figure 2D), such that
neurons that are generated early on reside in the deepest layers, whereas last-born cells
migrate past the existing layers to form the superficial layers (Rakic, 1988).
Consequently, the MZ and subplate contain the earliest-generated neurons of the cerebral
cortex. Those in the MZ (layer I) differentiate into Cajal-Retzius cells and other types of
neuron that have not yet been fully characterized. The subplate is separated from the VZ
by the intermediate zone (IZ), a layer that will eventually contain the afferent and efferent
axons of the cortex (white matter).
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As the CP emerges, another layer of proliferating cells appears between the VZ and IZ,
the so-called subventricular zone (SVZ). This germinal zone contains cells, produced in
the VZ, that give rise mainly to glia. The SVZ expands greatly in late gestation and in
early postnatal life as the VZ disappears.
Similarly (though later in development), neocortical astrocytes are born in the germinal
zone of the neocortex and then migrate locally within this structure. In contrast, two other
neocortical cell types, GABAergic interneurons and oligodendrocytes, arise from the
germinal zone of the ventral telencephalon and make long journeys, following tangential
migratory routes, to their final destinations in the neocortex (Corbin et al., 2001;
Parnavelas, 2000)(figure 1)
Figure 1 Diagram of the developing telencephalon illustrating the origin of the neural cell types that make
up the neocortex (modified from (Ross et al., 2003)). Pyramidal glutamatergic neurons and cortical
astrocytes arise from the proliferative layer of the dorsal telencephalon (blue). GABAergic inhibitory
interneurons are born in the proliferative zone of the ganglionic eminences (orange). Oligodendrocytes
arise from a discrete pool of progenitors in the most ventral region of the telencephalon (green). Not shown
are cell types that originate in the ventral telencephalon and remain in the basal ganglia, such as striatal
astrocytes and cholinergic neurons.
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Figure 2 Neocortical development (modified from (Nadarajah and Parnavelas, 2002).
(A) Schematic diagram of a section through the developing rodent forebrain.
(B-C) Illustrations of the different stages of neocortical development. The lateral ganglionic eminence
(LGE) and medial ganglionic eminence (MGE) of the ventral forebrain generate the neurons of the basal
ganglia and the cortical interneurons; the latter follow tangential migratory routes to the cortex (A; arrows).
In the dorsal forebrain (A; boxed area), neuronal migration begins when first cohort of postmitotic neurons
moves out of the ventricular zone (VZ) to form the preplate (PP) (B). Subsequent cohorts of neurons
(pyramidal cells) migrate, aided by radial glia, through the intermediate zone (IZ) to split the PP into the
outer marginal zone (MZ) and inner subplate (SP)(C). CP, cortical plate.
(D) Cortical cells obey an inside-first outside-last program of neurogenesis.
Neurons born within the ventricular zone at early stages migrate to the deepest layers of the cortical plate.
Neurons generated at later stages migrate past the earlier-generated neurons to form the more superficial
layers of the cortex.
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1.3 Basic Helix-Loop-Helix factors in cortical development
Recent insights into the molecular mechanisms regulating cortical development, have
shown that proliferation, specification, and differentiation of cortical progenitor cells is
controlled, to a large degree, by transcription factors with basic helix-loop-helix (bHLH)
motifs. The bHLH transcription factors (named in reference to the structural motif that
mediates their DNA binding and dimerization functions) (Murre et al., 1989) are a large
family with around 125 members encoded in the human genome (Ledent et al., 2002). A
small set of bHLH factors have been shown to have important roles during corticogenesis
(figure 3). This set of bHLHs can be divided in 2 groups based on their function during
cortical development: either inhibiting or promoting progenitors differentiation. Together
they have been implicated in the four principal stages of cortical development: the
proliferation of cortical progenitors, and subsequent the sequential formation of neurons,
astrocytes, and oligodendrocytes.
Figure 3 bHLH factors involved in cortical development (modified from (Ross et al., 2003)).
*Atonal is the Drosophila homolog of Math1, not NeuroD
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1.3.1 Maintenance of neural progenitors
Two classes of inhibitory bHLH proteins, Hes and Id factors, employ multiple strategies
to maintain cortical progenitors in a proliferative state, and to regulate the timing of their
differentiation.
The important role of Hes factors during neural development was first revealed in
Drosophila, where the Hes homologs, the Enhancer of split (E (spl)) family, were shown
to be negative regulators of neuronal differentiation (Knust et al., 1987).
In mammals, it has been shown that Hes1 and Hes5 have key roles in telencephalic
development (Ohtsuka et al., 1999). Both Hes1 and Hes5 are expressed in the ventricular
zone throughout the telencephalon where they sustain progenitors in an undifferentiated,
proliferative state and inhibit their differentiation into neurons. To achieve this goal, Hes
factors use two mechanisms. First, they form homodimers and heterodimers with closely
related family members, and bind to DNA elements called N boxes (CACNAG) to
repress the expression of target genes, such as Mash1, that are required for neuronal
differentiation (Chen et al., 1997; Davis and Turner, 2001) (figure 4A). The
transcriptional repression activity of Hes proteins is mediated by their interaction with
transcriptional corepressors of the Groucho/transducin-like enhancer of split (Gro/TLE)
family. Paroush et al. have used a yeast two-hybrid system, to identify proteins
interacting with hairy, a basic-helix-loop-helix (bHLH) protein that represses
transcription during Drosophila embryonic segmentation. They find that the Gro  protein
binds specifically to hairy and also to hairy-related bHLH proteins encoded by deadpan
and the Enhancer of split complex. The C-terminal WRPW motif present in all these
bHLH proteins is essential for this interaction. They demonstrate that these associations
reflect in vivo maternal requirements for Gro during neurogenesis, segmentation, and sex
determination, three processes regulated by the above bHLH proteins, and they propose
that Gro is a transcriptional corepressor recruited to specific target promoters by hairy-
related bHLH proteins (Paroush et al., 1994). The histone deacetylase activity associated
with this repressor complex modifies chromatin structure, making DNA inaccessible to
transcription (reviewed in (Naar et al., 2001).
The second mechanism by which Hes factors inhibit progenitor differentiation is through
a physical interaction with proneuronal bHLH proteins, resulting in a functional
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antagonism of the activity of proneuronal bHLH proteins (figure 4B) (Alifragis et al.,
1997; Sasai et al., 1992). Much of our understanding of Hes function comes from the
appreciation that Hes1 and Hes5 are key target genes that are transactivated in response
to Notch signaling (reviewed in (Justice and Jan, 2002). Accordingly, disruption of
Notch/Hes signaling through loss of Notch, Hes1, or Hes5 results in similar CNS
phenotypes, including premature neuronal differentiation in vitro and decreased
proliferative ability in vivo (de la Pompa et al., 1997; Ishibashi et al., 1994). Moreover,
the ability of Notch to inhibit neuronal differentiation is dependent on Hes1 and Hes5. In
cortical progenitors from Hes1-/-;Hes5-/- mice, constitutively active Notch signaling is
unable to block neurogenesis (Ohtsuka et al., 1999).  Ohtsuka et al. found, by retrovirally
misexpressing the constitutively active form of Notch (caNotch) in neural precursor cells
prepared from wild-type, Hes1-null, Hes5-null and Hes1-Hes5 double-null mouse
embryos, that caNotch, which induced the endogenous Hes1 and Hes5 expression,
inhibited neuronal differentiation in the wild-type, Hes1-null and Hes5-null background,
but not in the Hes1-Hes5 double-null background. These findings indicate that Hes1 and
Hes5 are critical Notch effectors that act to promote the maintenance of cortical
progenitors by blocking their differentiation into neurons.
Notch/Hes signaling may function during cortical development to maintain a balance
between the number of developing neurons and the number of remaining progenitors by a
phenomenon known as lateral inhibition (reviewed in (Beatus and Lendahl, 1998). This
process provides a mechanism by which a progenitor gives rise to nonequivalent
descendents. Newly formed neurons up regulate the Notch ligand, Delta, as they
differentiate, and Delta activates Notch/Hes signaling in adjacent cells to block
progenitor differentiation. Lateral inhibition thus allows the differentiation of some
cortical progenitors into neurons, while preventing simultaneous neurogenesis of all
cortical progenitors. As newly differentiating neurons migrate out of the ventricular zone,
lateral inhibition in the ventricular zone diminishes, thereby allowing a new set of cortical
progenitors to begin neuronal differentiation.
The second class of inhibitory bHLH proteins is the Id factors. They are expressed in the
ventricular zone of the telencephalon (Jen et al., 1997), and inhibit gene transcription by
sequestration (Benezra et al., 1990; Ellis et al., 1990; Garrell and Modolell, 1990).
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Specifically, Ids form dimers with E proteins (E12, E47, E2-2, HEB) and thereby inhibit
the activity of bHLH factors that require E proteins (including Mash1, NeuroD,
Neurogenin and Olig families),(figure 4C). Id factors lack a DNA binding region and as
consequence, Id/E proteins heterodimers do not bind DNA. Ids inhibit the premature
differentiation of cortical progenitors into neurons and oligodendrocytes, but not
astrocytes. In mouse models lacking both Id1 and Id3, cortical progenitors exit the cell
cycle prematurely and undergo accelerated neuronal differentiation in vivo (Lyden et al.,
1999). Similarly, when oligodendrocyte precursors from Id2 knockout mice are cultured
in vitro, they undergo precocious growth arrest and differentiation, yielding premature
oligodendrocytes (Wang et al., 2001). Forced expression of Ids in cell culture blocked
both neurogenesis and oligodendrocyte formation (Kondo and Raff, 2000; Toma et al.,
2000; Wang et al., 2001). In addition to their role as temporally regulated inhibitors of
neuronal and oligodendroglial differentiation, the Id family members, Id2 and Id4, have
been shown to play a role in promoting cell proliferation by inhibiting the ability of
retinoblastoma (Rb) family members to interfere with E2F-mediated transcription
(Iavarone et al., 1994; Lasorella et al., 1996; Norton, 2000) (figure 4D). Transcription
factors of the E2F family induce the transcription of genes that mediate cell cycle
progression. Members of the Rb family interact physically with E2F transcription factors
and block their activity. Id2 and Id4 function, in part, by releasing E2Fs from inhibition
by Rb, such that E2Fs can activate genes that promote the proliferation of cortical
progenitors. It is not clear how the activity of Ids is regulated. One possibility may be the
control of Id entry into the nucleus. Since they lack a nuclear localization sequence, the
localization of Ids depends upon their interaction with nuclear proteins such as E
proteins. Recently it was found, for example, that Id2 relocalizes from the nucleus to the
cytoplasm at the onset of oligodendrocyte differentiation (Wang et al., 2001).
It is through these various mechanisms, therefore, that Hes and Id family members are
believed to function in maintaining neural progenitors in non differentiate state.
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Figure 4 Mechanisms of bHLH factor activity (modified from (Ross et al., 2003)).
(A) Hes factors form homodimers and heterodimers within their class and bind to DNA elements called N
boxes (CANNAG) to repress the expression of target genes. Transcriptional repression is mediated by the
interaction of Hes proteins with corepressors, such as Groucho/TLE, which recruit large repressor
complexes.
(B) Recent work in Drosophila suggest that Hes proteins may inhibit the transcription of genes at which
proneural bHLH/e protein dimers are bound through direct interaction with proneural bHLH. Experiments
are required to determine whether this mode of repression is conserved in mammals.
(C) Ids inhibit bHLH activity sequestering E proteins away from bHLH factors.
(D) Ids promote proliferation by inhibiting the ability of Rb to interfer with E2F-mediated transactivation
of genes that are critical for cell cycle progression.
(E) bHLH dimerize with E proteins and bind to DNA elements called E boxes (CANNTG).
1.3.2 Formation of neurons
The initial phases of cortical development involve the rapid proliferation of cortical
progenitors through symmetric division in which one cell gives rise to two identical
proliferating daughter cells. At the time of neurogenesis, however, a subset of cortical
progenitors becomes restricted to a neuronal lineage. It is likely that this restriction
involves asymmetric division in which one cell is maintained as a multipotent cortical
progenitor, while the other is fated to differentiate into a neuron within a few rounds of
cell division. The transition from proliferation to neurogenesis involves a coordinate
increase in proneural bHLH activity and a decrease in Hes and Id activity.
Neurogenesis is mediated by two broad categories of bHLH factors, proneural bHLH
factors (Ngns and Mash1), which are involved in initiating neurogenesis, and neuronal
differentiation bHLH factors (e.g. NeuroD), which are involved in mediating terminal
differentiation. Proneuronal bHLH factors and neuronal differentiation bHLH factors are
transcriptional transactivators. These proteins bind DNA as heterodimeric complexes
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together with E proteins. The basic domain of these bHLH factors mediates interaction
with DNA sequences that contain the core hexanucleotide motif CANNTG, known as the
E-box (figure 4E) (Bertrand et al., 2002). Transactivation is mediated by interaction of
bHLH heterodimers with coactivators, such as p300/CBP, which recruit a large complex
that includes the basal transcriptional machinery.
Three proneural bHLH factors are known to be expressed in the telencephalon, Ngn1,
Ngn2, and Mash1(Guillemot and Joyner, 1993; Sommer et al., 1996). During
development, these bHLH factors are expressed at low levels while neural progenitors are
being specified, and a transient increase in their expression occurs at the initiation of
neurogenesis. Proneural bHLH factors are expressed in the ventricular zone, where
progenitors begin to be differentiate, but are not expressed in the cortical plate, where
fully differentiated neurons are situated. Ngns are expressed in the dorsal telencephalon,
which gives rise to glutamatergic neurons, whereas Mash1 is predominantly expressed in
the ventral telencephalon, which gives rise to GABAergic and cholinergic neurons,
suggesting the possibility that different proneural genes are involved in the specification
of different neuronal subtypes (Wilson and Rubenstein, 2000). An important role for
proneural bHLH factors in the telencephalic development has been revealed by loss-of-
function studies. In the Mash1 knockout mouse, the decrease in proneural bHLH activity
causes a loss of progenitor cells in the ventral telencephalon, resulting in loss of
GABAergic interneurons in the cortex (Casarosa et al., 1999). In the Ngn2 knockout
mouse there is an up regulation of Mash1 found in the dorsal telencephalon, resulting in
the differentiation of some progenitors into GABAergic neurons in this region (Fode et
al., 2000). The signaling pathways that positively regulate the activity of proneural
factors are unknown.
The transient expression of proneural bHLH factors induces a second, sustained wave of
bHLH differentiation genes, which mediate the terminal differentiation of neurons
(Kageyama and Nakanishi, 1997; Lee, 1997). These differentiation genes are members of
the NeuroD/Nex family, and include NeuroD, NeuroD2, NeuroD related factor (NDRF),
and Nex (Math2). Like proneural bHLH factors, bHLH differentiation proteins are E box
binding transcriptional activators, whose expression begins in the immature neuron and is
maintained during neuronal differentiation (Lee et al., 2000). Thus these factors are
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expressed in the cortical plate, but not in the ventricular zone (Schwab et al., 1998).
Although there is strong evidence from studies of knockout mice that the NeuroD/Nex
family of genes is required for the differentiation of glutamatergic neurons in the
hippocampus and cerebellum, no phenotypes has been reported in the neocortex for the
single knockouts (NeuroD, NeuroD2, or Nex2) or the neuroD/nex1 double knockout
(Miyata et al., 1999; Olson et al., 2001; Schwab et al., 2000). These findings suggest that
members of the NeuroD family function in a largely redundant manner.
1.4 C/EBP transcription factors
1.4.1 C/EBPs: homology regions
The C/EBP proteins are a subfamily of the basic-region leucine zipper (BR-LZ)
transcription factor family. In vertebrates, the family consist of six members namely
C/EBPa, C/EBPb ,  C/EBPd, C/EBPg, C/EBPe, and C/EBP z   (Akira et al., 1990;
Antonson et al., 1996; Birkenmeier et al., 1989; Cao et al., 1991; Descombes et al., 1990;
Poli et al., 1990; Ron and Habener, 1992; Thomassin et al., 1992; Xanthopoulos et al.,
1989).
C/EBP proteins have also been found in invertebrates, such as Aplysia and Drosophila,
although in these organisms only one C/EBP protein exists (Alberini et al., 1994; Montell
et al., 1992).
The proteins of the C/EBP family share features in structure as well as function.
The structural similarities of the C/EBP family members are mostly in the C-terminal
BR-LZ domains. The basic region contains the DNA binding specificity of the proteins
(Agre et al., 1989; Suckow et al., 1993) but may also have other functions. The LZ is a a-
helical dimerization domain, and the various C/EBP factors are known to dimerise
through this domain with other members of the family, as well as with BR-LZ factor
ATF4 of the CREB family (Williams et al., 1991). Early experiments predicted that the
only function of the LZ domain was to ensure dimerization of C/EBP factors: in fact, a
zipper exchange mutant of C/EBPa, containing the LZ domain of the yeast protein
GCN4, showed DNA binding ability comparable with wild type C/EBPa (Agre et al.,
1989). Moreover, this Gz mutant was also able to substitute for the biological function
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(embryonic survival) of Drosophila C/EBP (Rorth, 1994). Subsequent experiments have
shown that dimerization is likely not the only function of the LZ domain of the C/EBP
factors. C/EBPa has been shown to display a much lower transactivational ability on the
albumin promoter in HeLa cells (a human cervical carcinoma cell lines) compared to
HepG2 cells (a rat hepatoma cell line), whereas the Gz mutant is equally active in both
cell types. This suggests that the LZ may mediate the cell type specific activity of
C/EBPa (Nerlov and Ziff, 1994).
The N-terminus of C/EBP proteins is not as conserved between the different isoforms as
the C-terminal BR-LZ domains, although there are areas of homology between the N-
terminals of C/EBPa, b, and d  (Nerlov and Ziff, 1995). In these proteins the N-terminus
contains the domains responsible for most, if not all, of the transcriptional activation of
the proteins (Friedman and McKnight, 1990; Kowenz-Leutz and Leutz, 1999; Nerlov and
Ziff, 1995). For C/EBPa, (Nerlov and Ziff, 1995) three transactivation elements have
been identified (termed TE-I 1-70aa, TE-II 71-96aa, TEIII 126-200 aa). TE-I and –II
contain the main regions of homology between the N-terminal transactivation domains of
C/EBP factors. Components of the basal transcription machinery (TBP and TFIIB) have
been shown to interact with TE-I and –II via aminoacids conserved between the
C/EBPa, b, d, isoforms (Nerlov and Ziff, 1995). These conserved domains also mediate
interactions between C/EBPs and pRB/p107 (Chen et al., 1996; Timchenko et al., 1999).
The anti-mitotic ability of C/EBPa has been proposed to require the N-terminus, as the
short form of C/EBPa is unable to induce growth arrest (Lin et al., 1993; Umek et al.,
1991). C/EBPa  has long been known as an anti-mitotic protein (Umek et al., 1991).
Several experiments have shown that C/EBPa expression is able to commit cycling cells
to growth arrest in cell cultures (Hendricks-Taylor and Darlington, 1995; Muller et al.,
1999; Timchenko et al., 1996; Umek et al., 1991). In C/EBPa, knock-out  mice, the
newborns display increased proliferation both in hepatocytes and in lungs (Flodby et al.,
1996; Timchenko et al., 1997). Similar function has not been demonstrated so far for
C/EBPb.
C/EBPa and C/E B P b  exist as different isoforms. Two isoforms of C/EBPa
are genetated from its mRNA  (Lin et al., 1993; Ossipow et al., 1993). The full length
protein of 42kDa and the shorter form of 30kDa. The p30 form acts as a dominant
INTRODUCTION
15
negative, however it is able to activate some promoters in transient transfections if
expressed alone (Lin et al., 1993; Ossipow et al., 1993). Also C/EBPb,  is found in
different forms encoded by the same mRNA. The full-length 35kDa protein, also termed
LAP (liver-enriched transcriptional-activator protein), encodes for the conserved
activation domain found in other C/EBP proteins, as well as two regulatory domains,
RD1 and RD2, which confer DNA binding inhibition in a cell type specific manner
(Williams et al., 1995). The truncated form 20 kDa, LIP (liver-enriched transcriptional-
inhibitory protein), possess only the DNA-binding and leucine zipper domains
(Descombes and Schibler, 1991; Poli et al., 1990). Heterodimerization of the truncated
isoform with full length C/EBPb, (LAP) attenuates transcriptional activity suggesting a
dominant negative mechanism of regulation (Descombes and Schibler, 1991). There is
also the form termed LAP* that cointains a conserved N-terminal extension termed CR1.
CR1 has been shown to mediate interaction with a vertebrate homologue of the yeast
SWI/SNF complex (Kowenz-Leutz and Leutz, 1999). C/EBPb,  is known to cooperate
with Myb to induce transcription of the granulocyte-specific mim-1 gene, Kowenz-Leutz
and Leutz show that the N terminus of the full-length C/EBPb isoform, which is essential
for induction of the mim-1 gene in chromatin, interacts specifically with the SWI/SNF
complex. Grafting this domain onto Myb generates a chimeric activator that recruits
SWI/SNF and induces mim-1 transcription in the absence of C/EBPb. Pedersen et al.
(Pedersen et al., 2001) demonstrated also, in adipocyte differentiation, that the
C/EBPa  transactivation element III (TE-III;(Nerlov and Ziff, 1994) is required for
adipose conversion, and  this region interacts with the SWI/SNF chromatin remodeling
complex during adipogenesis.
1.4.2 C/EBPs in neuronal cells
The vertebrate C/EBP transcription factors are expressed in many tissues and have
specific functions in a number of specialized cells including granulocytes, adipocytes,
hepatocytes, granulose cells, macrophages, mammary epithelium, keratinocytes, neurons
and astrocytes (Birkenmeier et al., 1989; Christenson et al., 1999; Kuo et al., 1990;
Seagroves et al., 1998; Zhang et al., 1997). Generally, C/EBPa, b, d, and e are expressed
in differentiated tissue, while C/EBPg and z have a more ubiquitous expression pattern
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(Lekstrom-Himes and Xanthopoulos, 1998). The C/EBPa, b, d, are expressed in the adult
nervous system, and in the embryonic telencephalon from E12 to E18, likely in both
progenitors and neurons (Menard et al., 2002). C/EBPb is widely expressed in the
hindbrain, midbrain and forebrain (Sterneck and Johnson, 1998). Astrocytes were
reported to express C/EBPb in vitro upon exposure to glutamate, norepinephine, or
certain neuropeptides (Cardinaux and Magistretti, 1996). In addition, distinct neuronal
populations express C/EBPb such as cerebellar purkinje cells and pyramidal and granule
cells, and possibly inhibitory neurons in the hippocampal formation (Kuo et al., 1990).
The function of the C/EBPs in the mammalian nervous system is not completely clear. In
in vitro studies C/EBPb has been shown to induce the differentiation of mouse Neuro2A
cells through the activation of the phosphatidylinositol 3-kinase pathway. C/EBPb also
seems to regulate C/EBPa gene expression in the same neuroblastoma cells, and this in
turn would play a role in the neuronal differentiation of these cells (Cortes-Canteli et al.,
2002). Expression of C/EBPb has also been reported in the PC12 cell line (Metz and Ziff,
1991), which undergoes differentiation to neuron-like cells in response to nerve growth
factor. In transactivation assays, NGF stimulates C/EBPb activity and mutation of the
phosphorylation site for MAPK in C/EBPb (Thr188) affects its capacity to transactivate
in a promoter-specific way (Sterneck and Johnson, 1998). Recently the MEK-C/EBP
pathway has been shown to have an essential role during growth factor regulated cortical
neurogenesis (Menard et al., 2002). Inhibition of either MEK (by using dominant
negative) or the C/EBP family of transcription factors (by using a recombinant
adenovirus expressing an acidic form of C/EBP (A-C/EBP) that strongly and selectively
binds to all C/EBP family members and inhibits their binding to DNA (Greenwel et al.,
2000; Krylov et al., 1997) inhibits neurogenesis, while expression of a C/EBPb mutant
that is a phosphorylation-mimic at a MEK-Rsk site enhances neurogenesis. Conversely
inhibition of C/EBP-dependent transcription enhances CNTF-mediated generation of
astrocyte from the same progenitor cells
In the invertebrate Aplysia, it has been shown that the transcription factor Aplysia
CCAAT enhancer-binding protein (ApC/EBP) plays an essential role in the consolidation
of stable long term synaptic plasticity (Alberini et al., 1994). More recent studies in
mammals have suggested an implication of C/EBPb and C/EBPd in long term 
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plasticity and memory consolidation in rat hippocampus (Yukawa et al., 1998).
Taubenfeld et al., blocked C/EBPb by injecting antisense oligodeoxynucleotides into
hippocampus of rats, and showed that consolidation but not reconsolidation of inhibitory
avoidance memory requires the expression of the transcription factor C/EBPb in the
hippocampus (Taubenfeld et al., 2001).  Sterneck et al demonstrated a selectively
enhanced contextual fear response in mice carrying a targeted genomic mutation in
C/EBPd (Sterneck et al., 1998). To examine the role of C/EBP-related transcription
factors in long-term synaptic plasticity and memory storage, Chen et al. have used the
tetracycline-regulated system and expressed in the forebrain of mice a broad dominant-
negative inhibitor of C/EBP (EGFP-AZIP), which preferentially interacts with several
inhibiting isoforms of C/EBP. EGFP-AZIP also reduces the expression of ATF4, a distant
member of the C/EBP family of transcription factors that is homologous to the Aplysia
memory suppressor gene ApCREB-2. Consistent with the removal of inhibitory
constraints on transcription, they find an increase in the pattern of gene transcripts in the
hippocampus of EGFP-AZIP transgenic mice and both a reversibly enhanced
hippocampal-based spatial memory and LTP. They suggest that several proteins within
the C/EBP family including ATF4 (CREB-2) act to constrain long-term synaptic changes
and memory formation. Relief of this inhibition lowers the threshold for hippocampal-
dependent long-term synaptic potentiation and memory storage in mice (Chen et al.,
2003).
Although insights into the functions of C/EBP have been gained from these studies, to
better understand the role of C/EBP family members in the central nervous system, it
may be necessary to knock-out two or three members at the same time in order to observe
the effect without compensation from the other members.
1.5 Neurotrophins signaling
The neurotrophins are a family of secreted proteins that potently regulate diverse
neuronal responses. Family members include nerve growth factor (NGF), brain-derived
neurotrophic factor (BDNF), neurotrophin-3 (NT-3) and neurotrophin 4/5(NT4/5).
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Neurotrophins bind two different classes of transmembrane receptor proteins, the Trks
and the neurotrophin receptor p75.
The Trk family of receptor tyrosine kinases derives its name from the oncogene that
resulted in its discovery (Barbacid et al., 1991). This oncogene was isolated in gene
transfer assays from a carcinoma and, when cloned, was found to consist of the first
seven of eight exons of nonmuscle tropomyosin fused to the transmembrane and
cytoplasmic domains of a novel tyrosine kinase. Consequently, the proto-oncogene was
named tropomyosin-related kinase (trk) and is now commonly referred to as trkA. The
trkB and trkC genes were subsequently identified because of their high homology to trkA
(Barbacid, 1994; Kaplan et al., 1991; Klein et al., 1991).
The neurotrophins bind the Trks receptor in a specific way. NGF is the preferred ligand
for TrkA, BDNF and NT4/5 are preferred for TrkB, and NT3 for TrkC. NT3 is also able
to bind with less affinity TrkA and TrkB. Whereas the tyrosine kinase domains are highly
related (80% amino acid identity), the extracellular domain are more divergent (figure 5)
Figure 5 The Trk receptors.
The Trk receptors are transmembrane glycoproteins of ~140 kD. They are tyrosine kinases with an
extracellular ligand-binding domain containing multiple repeats of leucine-rich motifs (LRR1-3), two
cysteine clusters (C1, C2), two immunoglobulin-like domains (Ig1, Ig2), and a single transmembrane
domain. Binding specificity of the Trk receptors is mostly determined by the second Ig-like domain,
whereby each Trk receptor binds the corresponding ligand through a distinct specific sequence.
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1.5.1 Signal transduction through the Trk receptors
Binding of the neurotrophins to the Trk receptors leads to receptor tyrosine
phosphorylation. Ligand-induced dimerization (Jing et al., 1992) results in the
phosphorylation of specific tyrosine residues, located in the so called activation loop of
the tyrosine kinase domain. Phosphorylation of these residues leads to an open
conformation of the receptor, resulting in its trans-phosphorylation, as well as allowing
the access of substrates to the kinase. Phosphotyrosine residues on Trk receptors act as
docking sites for adapter molecules (figure 6). Two specific phosphorylated tyrosine
residues, located in the juxtamembrane domain (Y490 in TrkA, Y515 in TrkB, Y516 in
TrkC) and in C-terminus (Y785 in TrkA; Y816 in TrkB), serve as docking sites for
adapter molecules (Obermeier et al., 1994; Stephens et al., 1994).
Phosphorylated Y490 (or Y515, and Y516), binds and phosphorylates the adaptor protein
Shc via its PTB (phosphotyrosine binding) domain (Dikic et al., 1995). The recent
identification of Shc analogs raises the question of recruitment of different Shcs that may
be specific for TrkA, TrkB, and TrkC.
Elimination of the shc-site in the trkB  (trkBSHC/SHC) gene revealed distinct responses of
this receptor to BDNF and NT4/5 (Minichiello et al., 1998). NT4/5-dependent sensory
neurons were mostly lost in the trkBSHC/SHC mutant mice, whereas BDNF-dependent
neurons were only modestly affected. Comparative analysis of trkBSHC/SHC and trkCSHC/SHC
mice reveal distinct requirements for the shc-site in TrkB and TrkC signaling in sensory
neurons in vivo (Postigo et al., 2002)*. Both receptors promote long-term survival of
sensory neurons in an shc site independent manner, however, target innervations of
sensory neurons was lost in trkBSHC/SHC mice, whereas target innervations and neuronal
function were maintained in trkCSHC/SHC mice. The juxtamembrane tyrosine is also the
docking site for another membrane anchored adaptor protein, FRS2 (Kouhara et al.,
1997), which is tyrosine phosphorylated in response to NGF and BDNF (Easton et al.,
1999).
*Postigo, A., Calella, A. M., Fritzsch, B., Knipper, M., Katz, D., Eilers, A., Schimmang, T., Lewin, G. R.,
Klein, R., and Minichiello, L. (2002). Distinct requirements for TrkB and TrkC signaling in target
innervation by sensory neurons. Genes Dev 16, 633-645.
  Paper in collaboration during my PhD studies. My contribution was at the level of biochemical analysis in
primary cortical neuron, and counts of vestibular neurons.
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Phosphorylation of Y785 (or Y816) induces the binding (via SH2 domain) and
phosphorylation of phospholipase C-g (PLC-g). Furthermore, phosphorylated Y785 also
leads to the association of TrkA with CHK (csk homologous kinase), which appears to be
involved in NGF-promoted neurite outgrowth via MAPK (Yamashita et al., 1999).
Three main signaling cascades are activated by the Trk receptors and their substrates.
First, the activation of the Ras/Raf/MEK/MAPK pathway results from the formation of a
variety of complexes of adapter molecules. Phosphorylated Shc leads to the activation of
the Ras/Raf/MEK/MAPK pathway (Nakamura et al., 1996). Phospho Shc binds to the
Grb2–SOS complex, which activates Ras, and MAP kinase is activated through Raf- and
MEK. Similarly, phosphorylated FRS2 recruits a complex of the tyrosine phosphatase
SHP-2/Grb2/SOS and activates Ras/Raf/MEK/MAPK (Kouhara et al., 1997) .
Other docking molecules seem to form complexes with Grb2/SOS, such as rAPS and
SH2-B (Qian et al., 1998). They were identified in developing neurons and may be
involved in neuronal differentiation. This complexity of activation allows a sustained
activation of the MAPK pathway in response to neurotrophins, as well as a fine-tuning of
the responses.
Second, IRS (insulin receptor substrates IRS-1 and IRS-2) and Gab-1 (Grb-associated
binder-1) are adapter proteins that mediate the association and activation of PI3K
(Holgado-Madruga et al., 1997), which does not directly interact with the Trk receptors.
PI3K is especially implicated in neuronal survival through the activation of PKB/AKT
kinase (Crowder and Freeman, 1998), resulting in the phosphorylation and inactivation of
the proapoptotic protein BAD of the Bcl-2 family (Datta et al., 1997). PKB/AKT also
leads to the phosphorylation of the Forkhead transcription factor, which controls the
expression of genes involved in cell death, such as Fas ligand (Brunet et al., 1999). Third,
the association of PLCg with Trk regulates intracellular Ca2+ levels and protein kinase C
activity through cleavage of the substrate PIP2 to DAG and IP3. Recent studies have
contributed to our understanding of the physiological functions of the PLCg pathway.
This include the stimulation of neurotrophin-mediated neurotrophin release from cells
(Canossa et al., 1997), and the regulation of  synaptic plasticity (Minichiello et al.,
2002)*. The importance of the PLCg pathway for synaptic plasticity was revealed in vivo
by mutating the recruitment site, Y816, to phenylalanine. Mice homozygous for the
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Y816F mutation (trkBPLC/PLC mutants) showed deficiencies in the induction of both the
early and late phases of hippocampal CA1 long-term potentiation (LTP). Results are
similar to those observed in animals in which a floxed trkB allele was deleted in the
postnatal forebrain using Cre recombinase expressed under the control of the CaMKII
promoter (Minichiello et al., 1999). Surprisingly, while the MAPK pathways have been
implicated in late phase hippocampal LTP, BDNF-dependent phosphorylation of MAPK
and the distribution of phospho-MAPK appear to be unaffected in cortical neurons of
trkBPLC/PLC mutants. In contrast, phosphorylation of CREB, CaMKII, and CaMKIV are
severely impaired in these neurons. Interestingly, expression of the zinc finger
transcription factor Egr-1 (Krox24, Zif268), which is a downstream target of both Ras-
MAPK and CREB signaling and has been shown to be important for hippocampal LTP,
is markedly reduced in the hippocampus of trkBPLC/PLC mutants.
1.5.2 Neurotrophins and cortical progenitors
Members of the neurotrophin family, including nerve growth factor (NGF), brain-derived
neurotrophic factor (BDNF) and neurotrophin-3 (NT-3), are probable candidates for
influencing the cell lineage of neural stem cell. This statement is based on the finding that
neurotrophins and their receptors, TrkA, TrkB, TrkC, or p75, are expressed in the
ventricular and subventricular zones at the onset of cortical neurogenesis, and in cultured
neural stem cells (Lachyankar et al., 1997);(Fukumitsu et al., 1998);(Benoit et al., 2001).
Several reports have described the effects of neurotrophins on neural stem cells in vitro.
NGF accelerated the proliferation of neural progenitor cells in conjunction with basic
fibroblast growth factor-2 (FGF-2) (Cattaneo and McKay, 1990). BDNF enhanced
neuronal differentiation of neurosphere forming neural stem cells (Ahmed et al., 1995),
and promoted the survival of cortical neurons (Ghosh et al., 1994) and neurons generated
from the forebrain subependymal zone (Kirschenbaum and Goldman, 1995).
*Minichiello, L., Calella, A. M., Medina, D. L., Bonhoeffer, T., Klein, R., and Korte, M. (2002).
Mechanism of TrkB-mediated hippocampal long-term potentiation. Neuron 36, 121-137.
Paper in collaboration during my PhD studies. My contribution was at the level of biochemical and
immunocytochemical analysis of primary cortical neuron, and immunohistochemistry.
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Figure 6 Signaling through the Trk receptors: the main pathways.
Neurotrophin binding to Trk receptors triggers dimerization leading to the activation of different signaling
pathways through recruitment of various adapter molecules. The main binding sites for Trk substrates are
two tyrosine residues that, on activation of the Trk receptors, become phosphorylated. Two complexes of
adapter molecules bind to the tyrosine residue located in the juxtamembrane region of the Trk receptor, the
Shc/Grb2/SOS and the FRS2/SHP-2/Grb2/SOS complex. Ras/Raf/MEK/MAPK induces the differentiation
of neurons and neurite growth. The PKB/AKT pathway mediates the survival functions of the
neurotrophins. The phosphorylated tyrosine in the C terminus recruits PLCg, which catalyses the cleavage
of the substrate PIP2 to DAG and IP3, with DAG inducing activation of PKC and IP3 leading to release of
calcium from internal stores.
NT-3 has been suggested to regulate cell cycle exit and neuronal differentiation of
cortical precursor cells (Ghosh and Greenberg, 1995), and promoted clonal expansion of
oligodendroglial precursor cells (Barres et al., 1994). More recently, however,
neurotrophins are also believed to participate in neuronal maturation processes, rather
than in neuronal fate determination (Takahashi et al., 1999). In addition it has been
demonstrated that in cortical progenitor cells BDNF and NT3, acting via TrkB and TrkC
respectively, promote survival and neurogenesis through two distinct and separable
INTRODUCTION
23
signaling pathways: the PI3-kinase pathway mediates survival, and the MEK pathway is
important for neurogenesis (Barnabe-Heider and Miller, 2003).
1.6 Proto-oncogene fos: complex but versatile regulation
The selective modulation of gene expression in response to temporal, spatial, and
environmental cues underlies a broad range of biological processes in the central nervous
system. To a large extent, the regulation of gene expression is mediated by alterations in
transcription rates that occur in response to the interaction of trans-acting transcription
control proteins (transcription factors) with cis-acting DNA sequence elements.
The fos proto-oncogene (c-fos) has provided a useful experimental tool for the study of
gene expression. In the majority of cell types, it is expressed at relatively low levels, but
it can be rapidly and transiently induced by a broad range of stimuli.
c-fos is a basic-region leucine-zipper protein, and it is a member of a class of “immediate
early” response genes (Almendral et al., 1988). A number of sequence elements within
the 5’-flanking region of the gene supply targets for various inducing agents. The serum
response element (SRE) has been described as a protein binding site required for the
induction of c-fos expression by serum (Treisman, 1985). The SRE is composed of at
least two indipendent transcriptional sub-elements: 1) a 20 base pair dyad symmetry
element (DSE) positioned from residues –317 to –298 (Greenberg et al., 1987) and 2) a
region comprising residues –303 to-281, the c-fos AP-1 site(Velcich and Ziff, 1990), with
sequence homology to the consensus binding for the transcription factors AP-1 (Lee et
al., 1987) and CREB (Montminy and Bilezikjian, 1987; Montminy et al., 1986). Both the
DSE and FAP element respond to a number of extrinsic factors. The DSE mediates
induction by serum, a number of polypeptide growth factors, 12-O-tetradacanoyl
phorbol-13 acetate (TPA) and cAMP (Gilman, 1988; Gilman et al., 1986; Greenberg et
al., 1987; Siegfried and Ziff, 1989; Stumpo et al., 1988). In addition, the DSE has been
shown to be a target for autorepression (Konig et al., 1989; Sassone-Corsi et al., 1988a;
Schonthal et al., 1989). Oligonucleotides containing FAP element are activated via TPA-,
cAMP -, and EGF-induced pathways (Fisch et al., 1987; Fisch et al., 1989a; Fisch et al.,
1989b; Siegfried and Ziff, 1990; Velcich and Ziff, 1990) The transcription factor named
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serum response factor (SRF) binds to the sequence element (CC(A/T)6GG), termed CArG
box (Minty and Kedes, 1986) within the DSE (Rivera and Greenberg, 1990; Treisman,
1986; Treisman, 1987). That binding was found to be necessary, but not sufficient, for
serum induction of the SRE (Norman et al., 1988; Treisman, 1987). In vivo footprinting
analysis shows that SRF is constitutively bound to the SRE in both quiescent and growth
factor stimulated cells (Herrera et al., 1989).This suggests that it is the transcriptional
activation of a complex of SRF and its accessory proteins that is regulated rather than
regulation of SRF DNA binding. The ternary complex factors (TCFs) are members of the
ets family of transcription factors. The TCF family members Elk-1 (Hipskind et al.,
1991), SAP-1 (Dalton and Treisman, 1994), and SAP-2/ERP/NET (Giovane et al., 1994;
Lopez et al., 1994) have been found to have a role in regulating the SRE. TCFs cannot
bind the SRE autonomously, but require protein-protein interactions with SRF in order to
bind the SRE (Janknecht and Nordheim, 1992; Shaw et al., 1989; Treisman et al.,
1992).The C-terminal of TCF (aa 352-399), contains several consensus mitogen activated
protein kinase (MAPK) phosphorylation sites. The TCFs have been found to be targets
for all three families of MAPKs: the extracellular signal-regulated kinases 1/2 (ERK1/2),
the jun-N-terminal kinases/stress activated protein kinases (JNK/SAPK), and the p38
kinase (Treisman, 1996; Whitmarsh and Davis, 1996). TCFs are stimulated by
phosphorylation of the C-terminal MAPK sites (Treisman, 1994; Treisman, 1996;
Whitmarsh and Davis, 1996), this mechanism provide the transcriptional activation. It has
been also shown that both p35-C/EBPb and p20-C/EBPb could interact with SRF in vivo
and that the interaction between SRF and p35-C/EBPb, but not between SRF and p20-
C/EBPb, is stimulated by activated Ras. The target for this Ras stimulation is Thr188 in a
consensus MAPK site in C/EBPb (Hanlon and Sealy, 1999).
In PC12 cells it has also been shown that E12 and C/EBPb bind to the SRE at sites
adjacent to the DSE (Metz and Ziff, 1991), but there is not much known about the
possible role for the E-box and the C/EBP binding site in the context of c-fos promoter,
one possibility could be a form of tissue specificity control.
Another regulatory element, in the c-fos promoter, is located between –57 to-63 in the
human, mouse and chicken c-fos gene and contains the calcium and cyclic (cAMP)
response element, it mediates rapid gene induction by elevated intracellular calcium and
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cAMP (Fisch et al., 1989b; Sassone-Corsi et al., 1988b; Sheng et al., 1988). The
induction of c-fos by calcium has been proposed to occur through phosphorylation of the
cAMP response element binding protein (CREB) which binds to this site in vivo (Sheng
et al., 1990)
1.7 mGif/TIEG1 transcription factor
The glial cell-derived neurotrophic factor (GDNF) is a distant member of the
transforming growth factor-b   (TGF-b)  superfamily reviewed in (Kingsley, 1994).
Yajima et al. (Yajima et al., 1997) reported a transcription factor that is the first nuclear
protein known to be induced by GDNF, thus designated murine GDNF inducible factor
(mGif). The cDNA was cloned in the course of investigating transcription factor that bind
to SP1 consensus sequences. Sequence analysis indicated that mGIF is homologous to the
human TGF-b inducible early gene (TIEG1) and human early growth response gene-a
(EGR-a). Subsequently also an other member of the family was cloned and called TIEG2
(Cook et al., 1998).
The human TIEG1 cDNA was originally isolated as a transcript that was rapidly induced
by TGF-b  in human osteoclasts (Subramaniam et al., 1995) instead EGR-a was cloned
from prostate carcinoma cells (Blok et al., 1995). TIEG1 and EGR-a have identical
aminoacid sequences except for 12 residues absent in the N-terminus of EGR-a. Further
studies demonstrated that the accumulation of TIEG1 cDNA was also regulated by bone
morphogenic protein-2 (BMP-2), epidermal growth factor (EGF), and estrogen
(Subramaniam et al., 1995; Tau et al., 1998). Instead EGR-a was induced by EGF and
repressed by androgens (Blok et al., 1995). The existence of three zinc finger domains in
the carboxyl terminus of the predicted proteins led to the hypotesis that TIEG1/ EGR-a
were inducible transcription factors with a possible role in mediating the effects of some
growth factors on the target cells. In fact the carboxyl-terminal three zinc finger DNA
binding domain allows TIEG1 to directly associate with GC-rich sequences of DNA in
target gene promoters (Johnsen et al., 2002a; Tanabe et al., 2001; Yajima et al., 1997).
The three zinc fingers are highly conserved between TIEG1 and the related transcription
factor TIEG2, suggesting that they may regulate the same sequences in target gene
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promoters (Cook et al., 1998). However, outside of the DNA binding domain, TIEG1 and
TIEG2 bear little sequence homology. Yet both factors are negative regulators of gene
transcription and contain an a-helical repression domain (Cook et al., 1999; Johnsen et
al., 2002a; Yajima et al., 1997; Zhang et al., 2001). This domain is capable of repressing
gene transcription when fused to a heterologous DNA binding domain and can directly
interact with the transcriptional co-repressor mSin3A (Cook et al., 1999; Zhang et al.,
2001)
The protein sequence of human TIEG1 is 88% identical to the murine mGif. The
sequence of  mouse TIEG1 (mTIEG1) is identical to that of mGif. However, previous
studies of mGif expression and mTIEG1 revealed a different tissue distribution pattern
(Fautsch et al., 1998; Yajima et al., 1997) that might be due to a different mouse strain
used for the two analysis. So we can assume that mGif and TIEG/TIEG1 are the same
transcription factor.
The mouse TIEG1 gene spans 7 kb and contains 4 exons that code for mTIEG1 (Fautsch
et al., 1998). Exon 1a is 149 bp long and contains a 5’ untraslated region that is 9 bp
shorter than that seen in human TIEG1. Exon 2 is 230 bp long and is separated from
exon3 by a small 94-bp intron. Exon 3 is 913 bp long and contains two of the three zinc-
finger motifs. Exon 3 and 4 are separated by 450 bp intron. Exon 4 contains the third
zinc-finger motif and the long 3’ untraslated region. In the human TIEG1 gene, an
additional exon was found 3’ of the first TIEG1 exon. This exon, designated 1b was
found to code for the 5’ end of EGR-a  (Blok et al., 1995). Comparison of the human
EGR-a specific exon to the entire span of the mouse gene did not reveal the high
sequence conservation seen with other exons from the TIEG gene (Fautsch et al., 1998).
However, the mouse TIEG1 gene contains an exon 3’ of the first TIEG1 exon (called 1c)
that codes for the 5’ end of an EST isolated from a cDNA library obtained from liver. But
the meaning of this finding is not well known. Although little sequence similarity can be
found between most of the introns of the mouse and human TIEG1 genes, an 87%
identity can be found over a 650 bp region immediately 5’ of human EGR-a specific
exon 1b and sequence conservation exist in the region upstream of exon 1a. As with the
human TIEG1 gene, no consensus TATA box sequences are found in the 5’ upstream
INTRODUCTION
27
region of the mouse gene. In addition the position of diverse SP1 binding sites, E-box,
CTF/JunB, AP2 sites are conserved.
Yajima et al identify different post-translationally modified sites in mGif/TIEG1 that
could be involved in signal transduction pathways modulating the expression of various
genes. In particular they found 10 Pro-X-X-Pro sequences, which are putative src
homology 3 (SH3) binding motifs (Yu et al., 1994) and 16 Ser/Thr-Pro sequences, which
may be targets for proline-directed kinases. Among these Ser/Thr-Pro sequences, six are
putative target sites for MAPK (Alvarez et al., 1991) two are for cyclin-dependent protein
kinase ( CDK) (Moodie et al., 1993) and one is for glycogen synthase kinase (GSK)
(Pelech, 1995).
About the function of mGif/TIEG1, at beginning it was characterized as a negative-acting
transcription factor that can be induced by GDNF in murine neuroblastoma cells (Yajima
et al., 1997). After TIEG1 was shown to play a unique role in TGF/Smad signaling by
down-regulating negative feedback through Smad7. By repressing Smad7 gene
transcription, TIEG1 is able to enhance transcription of important TGF-regulated genes
such as the cyclin-dependent protein kinase inhibitor p21 and the plasminogen activator
inhibitor-1 (PAI-1) (Johnsen et al., 2002a). Johnsen et al (Johnsen et al., 2002b) described
also the identification of an E3 ubiquitin ligase, Seven in Absentia homologue-1
(SIAH1), as a TIEG1-interacting protein. They showed that TIEG1 and SIAH1 interact
through an amino-terminal domain of TIEG1. Co-expression of SIAH1 results in
proteasomal degradation of TIEG1 but not of the related factor TIEG2. Importantly, co-
expression of SIAH1 completely reversed repression of Smad7 promoter activity by
TIEG1. Furthermore, overexpression of a dominant negative SIAH1 stabilizes TIEG1
and synergizes with TIEG1 to enhance TGFb/Smad-dependent transcriptional activation.
These findings suggest a novel mechanism whereby the ability of TGFb to modulate
gene transcription may be regulated by proteasomal degradation of the downstream
effector TIEG1 through the SIAH pathway. Overexpression of TIEG1 mimics TGFb
action in several cell types by modulating differentiation markers, decreasing
proliferation, and inducing apoptosis (Chalaux et al., 1999; Hefferan et al., 2000; Ribeiro
et al., 1999; Tachibana et al., 1997). Accumulating in vitro and clinical data in the
literature suggests that TIEG1 serves a tumor suppressor role because overexpression
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reduces proliferation and induces apoptosis(Chalaux et al., 1999; Hefferan et al., 2000;
Ribeiro et al., 1999; Tachibana et al., 1997). Further support for this role arose from
studies demonstrating a decrease in TIEG1 protein levels that coincides with the
increasing stages of cancer in breast tumor biopsies (Subramaniam et al., 1998)
In vivo analysis revealed that mGif/TIEG1 mRNA in the adult mouse is present in heart,
lung, brain, liver, kidney, and testis  but not in spleen or skeletal muscle (Yajima et al.,
1997). The distribution of mGif/TIEG1  mRNA was also examined in the adult mouse
brain by in situ hibrydization and it was found in several region particularly in
hippocampus, cerebral cortex, amygdala, and cerebellum, with weaker signals in
striatum, substancia nigra, and thalamus (Yajima et al., 1997). The expression pattern
reassemble for some aspects that from TGF-b and GDNF (Yajima et al., 1997). Also
during embryogenesis at E16.5 mGif/TIEG1  is widely expressed in kidney and intestine,
including the enteric nervous system, consistent with the fact that GDNF-null mutant
mice lack kidneys and enteric neurons (Moore et al., 1996; Schuchardt et al., 1994;
Schuchardt et al., 1996) and that GDNF mutations are associated with the human
intestinal disorder Hirschsprung (Angrist et al., 1996; Ivanchuk et al., 1996). During
embryogenesis mGif it also expressed in cerebral cortex and cerebellar primordial and the
dorsal hedge of spinal cord.
It would be interesting to have mGif-null allele mice to better understand the function of
this transcription factor in vivo.
1.8 The Thesis Project
Evidence suggest that neurotrophins, in particular NGF, BDNF and NT3, may play a role
in regulating cortical progenitor cell biology, but their precise role for this biological
function is still unclear, as are the signaling mechanisms.
During my PhD I have focused my interest in understanding which set of transcription
factors mediate the functions of BDNF in cortical formation.
In order to answer this question, I adopted the following approaches. First, I analyzed
global changes in gene expression after BDNF/TrkB activation in primary cortical
neurons, using microarray technology. Second, once a set of regulated genes was
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identified, I characterized the regulation of these genes at the promoter level, in order to
understand which common elements are important for their regulation. This information
has contributed to our understanding of which transcription factors mediate BDNF/TrkB-
dependent gene expression in primary cortical neurons isolated at the peak of
neurogenesis.
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2.1 Differential regulation of immediate early genes induced by BDNF
through the shc-site or the plc-g site of TrkB receptor.
To examine the global changes in gene expression in response to BDNF/TrkB activation
in cortical neurons at the peak of neurogenesis, we performed an Affymetrix analysis.
The RNA used was obtained from cortical neurons isolated from E15.5 wild-type mouse
embryos. The cells were cultured for 24 hours and then stimulated for 1 hour with 50
ng/ml of BDNF in the absence of serum. The mRNA was then used as a probe to screen
oligonucleotide arrays (Affymetrix, Inc. UV74v2), which contained approximately 6000
annotated genes and 6000 EST sequences. The microarray analysis was repeated three
times with three different mRNA preparations and gave very similar results. 1.6% of the
genes present on the array showed at least two fold changes in expression and fell into
diverse classes: transcription factors, metabolic enzymes, kinases and unknown genes.
Having identified a group of regulated immediate early genes (IEGs), we sought to assess
the contribution of individual cytoplasmatic tyrosines of the TrkB receptor on the
induction of these IEGs. For this purpose we analyzed mutants of TrkB carrying Y-F
point mutations. From previous studies using PC12 cells it was established that the most
important tyrosines, mediating TrkB signaling are: Y515, in the juxtamembrane region of
the TrkB receptor, and Y816, in the C-terminal region. To investigate how the identified
IEGs are regulated by the mutant TrkB receptors, we obtained mRNA from primary
cortical neurons of E15.5 mouse embryos of trkBSHC/SHC, TrkBPLC/PLC, and their
respective controls, trkB+/+ or trkBWT/WT embryos, and screened an Affymetrix array.
Moreover, we also tested mRNA from cortical neurons of embryos carrying a double
point mutation (shc-site, plc-g site) in the TrkB receptor.
As shown in the figure 7 (A-B) the selected genes, which were induced 2 fold in the
control cells following BDNF stimulation, were down regulated in trkBSHC/SHC mutants
and up regulated in the trkBPLC/PLC mutants compared to controls.
These results suggest that the pathway/s activated through the shc-site promote a higher
activation of gene expression in response to BDNF than pathways activated through the
plcg-site.
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Figure 7 Identification of immediate early genes induced by BDNF at peak of neurogenesis by Affymetrix
analysis.
(A-B) Genes up-regulated upon two fold induction in trkBSHC/SHC mutants compared to trkB+/+ (A) and in
the trkBPLC/PLC mutants compared to its own control trkBWT/WT (B). The mRNA for the Affimetrix analysis
was obtained from E15.5 primary cortical neurons from the different mouse strains, the neurons were either
left unstimulated or stimulated with BDNF for 1 hr. The fold change was averaged from three independent
stimulated samples as compared to three independent unstimulated samples. n= number of samples for each
group. The BDNF-induction of genes is reduced in trkBSHC/SHC mutant mice and increased in the trkBPLC/PLC
compared to their controls.
(C) Fold inductions for the most highly regulated transcription factors in the different signaling point
mutant mice.
(D-E) BDNF induces c-fos, mGif, and Egr1 mRNA. Total mRNA from wild type primary cortical neurons,
either untreated or treated with BDNF at different time points, was analyzed on Northern blots using cDNA
specific for c-fos, (D upper panel). Blots were stripped and reprobed with cDNA for mGif  (D middle
panel) or GAPDH  (D lower panel) to evaluate loading. A new blot was used to check Egr1 expression (E
upper panel), the blot was stripped and reprobed with cDNA for GAPDH  (E lower panel) to evaluate
loading. The experiment was repeated three times. Similar kinetics of transcription were observed for the
different genes with peak expression occurring 1 hr after BDNF stimulation
RESULTS
33
2.2 A group of transcription factors show the same activation pattern
To identify genes with a similar expression pattern after BDNF induction, we used the
GeneSpring software to analyze the Affymetrix data. Using a self-organizing map (SOM)
the genes were clustered into 20 groups. Within the same group, using the correlation
factor of 0.9, we found genes that shared a statistically similar expression pattern. Among
these genes, the ones with the highest fold inductions were found to be the transcription
factors: c-fos, Egr1, egr2, and mGif.
As shown in the figure 7C, these genes were found to be differentially regulated in the
signaling point mutant mice, specifically they were down-regulated in trkB/shc point
mutants, and up-regulated in the trkB/plc-g point mutants. In the double mutants they
were down regulated with the exception of egr2. The expression of this gene was down
regulated in the absence of the shc-site, up regulated in the absence of plcg-site, whereas
in the absence of both sites its expression level did not change compared to knock in
controls.
As shown in the figure 7(D-E), northern blot analysis confirmed that the mRNA
induction of c-fos, Egr1 and mGif displayed similar kinetics, with a peak in expression
occurring after 1 hour of BDNF stimulation.
Therefore, BDNF treatment of cortical neurons at the peak of neurogenesis results in the
induction of c-fos, Egr1 and mGif expression; each showing the same kinetics of
activation, as well as the same mode of regulation as revealed using the signaling point
mutant mice.
2.3 Mutations at C/EBP and E-box sites on the c-fos promoter decrease
its activity
Having identified c-fos, Egr1 and mGif as a group of transcription factors whose
expression is similarly regulated by TrkB/BDNF during neurogenesis, we first looked at
their promoters to determine if they shared common elements that could explain their
similar regulation. Although the promoter of mGif/TIEG1 is not yet characterized, and
the function of this gene is not completely clear (Yajima et al., 1997) (Fautsch et al.,
1998), those of Egr1 and c-fos are well characterized, and several data suggest that these
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genes share cis acting 5’ regulatory elements (Janssen-Timmen et al., 1989; Sukhatme et
al., 1988). These elements include SRE, which binds the SRF complex, a binding site for
C/EBP, an E-box, which binds bHLH family members, and an AP1 site. Given the
similarity of the promoters, we choose the c-fos promoter as a model (figure 8), to better
understand which elements and transcription factors are important for BDNF-dependent
gene expression. This question was addressed using E15.5 cortical neurons transfected
with a wild-type c-fos promoter luciferase reporter plasmid, and examining the activation
of this promoter following BDNF stimulation.
Figure 8 The c-fos promoter. Schematic representation of the proximal (-700 bp) c-fos promoter showing
the location and sequence of the major responsive elements in different colors.
We initially performed a time course of luciferase activity following 50 ng/ml of BDNF
stimulation in wild-type cortical neurons to determine the maximum luciferase activity,
which was found to be between two and four hours (figure 9A). Given these results, we
performed the subsequent experiments using two hours of BDNF induction.
At this point we wanted to know how the point mutations of tyrosine 515 and 816 in
TrkB receptors affected the activation of the c-fos promoter. Using luciferase reporter
gene constructs transfected in E15.5 cortical neurons isolated from wild-type and
signaling point mutant mice, we discovered that the two sites (Y515, Y816) could
compensate for each other, although the pathways activated through the shc-site
promoted higher activation of c-fos promoter than pathways activated through the plcg-
site, and the two sites are both required for BDNF-dependent activation of the c-fos
promoter (trkBPLC/PLC and trkBD/D p<0.01) (figure 9B).
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Figure 9. Analysis of transcriptional activation of the c-fos promoter after BDNF treatment of primary
cortical neurons (next page).
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(A)Time course of luciferase activity following BDNF stimulation of wild-type cortical neurons.
E15.5 plus 4DIV primary cortical neurons from wild type mice were transfected with 2.3 mg of c-fos
promoter luciferase reporter plasmid and 3mg of pRSV-b-gal. Twenty-four hours after transfection, cells
were left unstimulated or stimulated with 50ng/ml BDNF at different time points. Relative luciferase unit
was defined as the ratio of b-galactosidase normalized luciferase activity from stimulated cells to the
normalized luciferase activity from unstimulated cells. Maximal luciferase activity was between two and
four hours.
(B) Point mutations of both tyrosines 515 and 816 in TrkB receptors reduce the activation of the c-fos
promoter.
E15.5 plus 4DIV primary cortical neurons from controls or different trkB mutants were transfected as
described in (A). Luciferase activity was measured after two hours of BDNF stimulation. Data are the
average of three independent experiments. The results are indicate as the mean ± standard error *p<0.01. It
is interesting and statistically significant that the pathways activated through the shc-site promoted higher
activation of c-fos promoter than pathways activated through the plcg-site. The two sites are required for
BDNF-dependent activation of the c-fos promoter since with a double mutantions the promoter was
minimally activated.
(C) The C/EBP binding site and E-box are fundamental for the activation of the c-fos promoter downstream
BDNF/TrkB.
E15.5 plus 4DIV primary cortical neurons from wild-type mice were transfected with 2.3 mg of wild-type
or mutated c-fos promoter luciferase reporter plasmids, and 3mg of pRSV-b-gal. Data are the average of
three independent experiments, and results are indicated as the mean ± standard error *p<0.005. Cells
transfected with a c-fos promoter mutated in both the C/EBP binding sites and E-box (pMcebp/ebox)
showed a significant decrease in luciferase activity. Instead, cortical neurons transfected with a plasmid
mutated in sre element together with the binding site for C/EBPs (pMSRF/cebp) revealed a significant
increment in the activation of the promoter. No significant differences in luciferase activity were observed
between the wild type c-fos promoter and the c-fos promoters mutated at the E-box alone (pMebox), E-box
cassette and AP1 binding sites (pMebox\AP1) or CRE (pMCRE), in response to BDNF.
(D-E) Combining TrkB receptor mutation at the shc-site or at the plcg-site with c-fos promoter elements
mutations decrease dramatically the activity of c-fos promoter.
E15.5 plus 4DIV primary cortical neurons from trkBSHC/SHC (D) and trkBPLC/PLC (E) mutants were
transfected as described in (C). Data are the average of three independent experiments, and the results are
indicate as mean ± standard error *p<0.001, **p<0.01. In the presence of point mutant TrkB receptors all
the sites on the c-fos promoter are important for its activation, except in the absence of both sre element
and C/EBPs binding sites (pMSRF/cebp) in the trkBSHC/SHC mutants (D).
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After examining the effect of mutations in the TrkB receptor on c-fos promoter activity,
we analyzed the different elements in the promoter responsible for the activation
downstream BDNF/TrkB. We used luciferase reporter gene constructs containing either
the entire wild-type promoter region, up to nucleotide –700, or a series of mutations that
progressively eliminated the known binding sites upstream of the transcriptional start site.
These mutations included: (i) no sre element combined with the absence of the C/EBP
binding site (pMSRF/cebp), (ii) absence of the C/EBP binding site and E-box
(pMcebp/ebox), (iii) absence of E-box alone (pMebox), (iv) absence of E-box and AP1
site (pMebox/AP1), and (v) absence of CRE (pMCRE). Some of these mutants were
provided from C.Nerlov (personal communication) and, the inserted mutations are
indicated:
i. pMSRF/cebp:   tgtccatcggaggacatctgcgtcagcaggtttccacggcc
ii. pMcebp/ebox:  tgtccatattaggaacgctgcgtcagcaggtttccacggcc
iii. pMebox/AP1:   tgtccatattaggacatccatggcagcaggtttccacggcc
iv. pMebox:  tgtccatattaggaaatctgcgtcagcaggtttccacggcc
v. pMCRE:   ccgtggttgagcccgtgatgtttacactcattcat
As shown in the figure 9C, in the presence of wild type receptors, the C/EBP binding site
together with the E-box are fundamental for the activation of the c-fos promoter
downstream BDNF/TrkB (pMcebp/ebox p<0.005). Instead, the absence of the sre
element and the C/EBP binding site induced a higher activation of the promoter
(pMSRF/cebp p<0.005). Possibly the absence of the SRF complex makes the promoter
more accessible to other transcription factors.
To better understand if the activation of a putative complex binding the C/EBP binding
site and E-box was downstream the shc-site or the plcg-site, we transfected the same
mutant constructs in E15.5 cortical neurons derived from point mutant mice. As shown in
the figure 9D-E, in the absence of the E-box and C/EBP binding sites the c-fos promoter
was no longer activated by BDNF in neurons from either trkBSHC/SHC (p<0.001) or
trkBPLC/PLC (p<0.001) point mutant mice. From the same figure it is clear that when the
receptor is mutated on either the shc-site or the plcg-site, all the elements in the c-fos
promoter become important for its activation (in trkBSHC/SHC pMebox, pMebox/AP1,
pMCRE p<0.001, in trkBPLC/PLC pMSRF/cebp, pMebox/AP1, pMCRE p<0.01, pMebox
RESULTS
38
p<0.001), except in the absence of both the sre and C/EBP binding sites in the
trkBSHC/SHC neurons, where there is no change in promoter activity in response to BDNF.
Taken together these results suggest that wild-type TrkB receptor is capable of activating
the c-fos promoter carrying mutations in its different elements, except in the absence of
both the C/EBP binding site and the E-box. On the contrary, a receptor mutated on either
the shc-site or plcg-site is not able to activate the c-fos promoter carrying mutations in
different elements.
2.4 Expression of C/EBPa and b, Mash1 and NeuroD peaks at the same
time in cortical neurons in vitro
The promoter analysis of c-fos suggested that C/EBPs and bHLH transcription factors
might collaborate to induce the activation of the c-fos promoter, or other promoters with
similar features, downstream of BDNF/TrkB during the peak of cortical neurogenesis. So
we examined cortical progenitors, isolated from E12-E13 embryos and cultured in the
presence of FGF2 (Gloster et al., 1999; Slack et al., 1998; Toma et al., 2000), for the
expression of C/EBPa and b, and bHLH transcription factors like Mash1 and NeuroD. At
this stage and in these conditions, the majority of the cells are proliferating, nestin-
positive progenitors, many of which exit the cell cycle and express the panneuronal
markers bIII-tubulin, neuron-specific enolase (NSE), MAP-2, neurofilament-M, and
NeuN.
As shown in figure 10, RT-PCR analysis demonstrated that C/EBPa and C/EBPb were
already expressed in neurons after 2 DIV, and showed a peak in expression after 4DIV.
Mash1, an early differention member of the bHLH family, showed the same expression
pattern as C/EBPs, while NeuroD, a late differentiation factor, appeared only after 4 DIV,
and remained highly expressed even after 6DIV. Thus, after 4DIV, we obtain a
population of cortical neurons that express C/EBPa, C/EBPb, Mash1 and NeuroD.
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Figure 10. Expression analysis of C/EBP, a and b, Mash1 and NeuroD by RT-PCR in cortical neurons.
Primary cortical progenitor cells were put in culture at E12.5 and harvested for total mRNA after 2 DIV,
4DIV and 6DIV. As a control cells were analyzed for ubiquitin levels of mRNA. Lanes 1 and 2 are two
different preparations of total mRNA from E12.5 cells after 2DIV, lanes 3 and 4 comes from E12.5 cells
after 4DIV, lanes 5 and 6 comes from E12.5 cells after 6DIV, lanes 7 and 8 are the same RNA of lines 5
and 6 without RT, lane 9 is water. Peak expression of C/EBPa,  C/EBPb, Mash1 and NeuroD occures after
4 DIV.
2.5 In vivo and in vitro interaction of C/EBPa and b with Mash1 and
NeuroD
We next asked if C/EBPa and b interacted with Mash1 and NeuroD at the time of the
peak of neurogenesis, and if this interaction was BDNF-dependent.
We performed biochemical analysis on primary cortical neurons, derived from wild-type
animals, either left unstimulated and stimulated with BDNF for 1 hour.
Immunoprecipitation assays showed that C/EBPb binds Mash1 and NeuroD, and that
binding is BDNF-independent (figure 11A-C). We also found that C/EBPa  binds
NeuroD in a BDNF-independent manner (figure 11D), and, like C/EBPb,  is able to bind
Mash1 (data not shown).
Because C/EBPa and C/EBPb have high homology in both the N-terminal and C-
terminal regions, we wanted to identify the domains on C/EBPa and b responsible for
these interactions. We performed an in vitro translation assay to label Mash1 or NeuroD,
followed by pull-down analysis using GST fused to the N-terminal region of C/EBPa,
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the C-terminal region of C/EBPa, or the C-terminal region of C/EBPb. As shown in the
figure 12A-B, NeuroD bound the C-terminal region of both C/EBP a and b, and not their
N-terminal region. Conversely, Mash1 bound to the N-terminal region of C/EBP a but no
binding was revealed in the presence of the C-terminal region of C/EBPa and b. To
verify the specificity of the binding we performed similar GST-pulldown experiments
using the same amount of in vitro translated Myogenin (another member of bHLH
family). As shown in figure 12C, there was no specific interaction between Myogenin
and the different domains of C/EBPa and b. These results indicate that Mash1 interacts
specifically with the N-terminal region of C/EBPa, whereas NeuroD interacts with the C-
terminal region of C/EBPa and b.
Figure 11 C/EBPa and C/EBPb bind Mash1 and NeuroD in BDNF-independent manner in vivo.
(A-C) BDNF-independent binding of C/EBPb with Mash1 and NeuroD.
Cortical neurons derived from wild-type animals were either left unstimulated or stimulated with BDNF for
1 hour. Nuclear extracts were immunoprecipitated with anti-C/EBPb antibody followed by immunoblotting
with anti-Mash1 antibody. The same blot was reprobed with anti-NeuroD and then with anti-C/EBPb  to
visualize protein level (A). Nuclear extracts were immunoprecipitated with anti-Mash1 antibody followed
by immunoblotting with anti-C/EBPb. The blot was reprobed with anti-Mash1 to visualize protein levels
(B). Nuclear extracts were immunoprecipitated with anti-NeuroD antibody followed by immunoblotting
with anti-C/EBPb. The blot was reprobed with anti-NeuroD to visualize protein levels(C).
(D) BDNF-independent binding of C/EBPa with NeuroD.
Nuclear extracts were immunoprecipitated with anti-NeuroD antibody followed by immunoblotting with
anti-C/EBPa.  The blot was reprobed with anti-NeuroD to visualize protein levels.
RESULTS
41
Since the C-terminal region of C/EBPs includes both a basic region and a leucine zipper,
we asked where the interaction with NeuroD occurs.
 We used different mutants of C/EBPa (provided by C. Nerlov) (Porse et al., 2001)
(figure 12D) containing mutated residues in the basic region that, based on molecular
models of the C/EBPa protein derived from the crystal structures of the related c-Fos, c-
Jun, and GCN4 proteins, are predicted to reside either on the non-DNA binding face of
the basic region a-helix (BRM1, -2, and –3), or beyond the residues involved in DNA
contact in known bZIP structures, but which are highly and specifically conserved in
C/EBP proteins (BRM5) (figure 12D). Immunoprecipitation analysis, in the presence of
labeled NeuroD and unlabeled wild-type C/EBPa or BRM mutants, revealed that BRM1
and BRM3, but not BRM2 and BRM5, were impaired in their ability to bind NeuroD
(figure 12E-F).
Moreover, replacement of the C/EBPa leucine zipper with the GCN4 leucine zipper had
no effect on the binding with NeuroD (figure 12E-F).
Taken together, our data indicate that Mash1 and NeuroD interact with C/EBPa and b in
a BDNF-independent manner, and that these interactions involve different domains of
C/EBPs: the N-terminal region for Mash1, and the C-terminal region for NeuroD.
Furthermore, our analysis reveals that the binding of NeuroD is impaired by specific
mutations in the non-DNA binding face of the basic region a-helix of C/EBPa.
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Figure 12 Mash1 and NeuroD interact with different domains of C/EBPs
(next page)
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(A) Interaction of NeuroD with C-terminal region of C/EBPa and b. In vitro translated NeuroD (5 ml;
500000 cpm ) was subjected to a pull-down with the indicated GST fusion proteins. After washing, bound
proteins were eluated and run on 12.5% SDS gel. Autoradiography revealed that NeuroD binds the C-
terminal region of C/EBPa and b (GST-CterC/EBPa,  GST-CterC/EBPb) and not the N-terminal region
(GST-NterC/EBPa). 
(B) Interaction of Mash1 with N-terminal region of C/EBPa. 
Similar analysis as shown in (A) was carried out using the same amount of in vitro translated Mash1.
Radioactive signals revealed that Mash1 binds the N-terminal region of C/EBP a (GST-NterC/EBPa) and
not the C-terminal region of C/EBPa and b (GST-CterC/EBPa, GST-CterC/EBPb). 
(C) Lack of interaction between Myogenin and diverse domains of C/EBP a and b.
Similar analysis as shown in (A) was carried out using the same amount of in vitro translated Myogenin as
negative control.
(D) Alignment of the c-Fos, cJun, GCN4, and C/EBPa basic regions. For the former three, the residues
implicated in DNA binding by X-ray crystallography (Protein Data Bank accession no. 1FOS and 1YSA)
are indicated below the sequence. Those positions where one or two amino acid residues account for all
four proteins are shown as a consensus sequence. The positions of the basic region mutations introduced
into C/EBPa are indicated below the C/EBPa sequence.
(E-F) Specific mutations in the basic region of C/EBPs affect the binding with NeuroD.
The same amount of in vitro translated NeuroD (5 ml; 500000 cpm) was incubated with the indicated
translated in vitro C/EBPa  proteins (wild-type and mutants). The mixtures were immunoprecipitated with
anti-C/EBPa antibody followed by autoradiography. The binding was impaired only in presence of BRM1
and BRM3 mutants. The similar amounts of unlabeled proteins were revealed by western blot using an
antibody against anti-C/EBPa (E).
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2.6 C/EBPs, Mash1 and NeuroD are constitutively bound at c-fos
promoter
Given that the interaction, between C/EBPa, C/EBPb, Mash1 and NeuroD appears to be
BDNF independent, we wanted to determine if the preformed complexes were also
present on the c-fos promoter independent of BDNF stimulation. UV-crosslinking assays
using nuclear extracts from cortical neurons of wild-type mice, either left unstimulated or
stimulated with BDNF for 1 hour, revealed the presence of Mash1 and NeuroD on the c-
fos promoter in the absence of BDNF (figure 13 A).
The occupancy of the c-fos promoter by C/EBPa and b, Mash1 and NeuroD was further
confirmed using chromatin immunoprecipitation. Soluble chromatin was prepared from
entire forebrain of wild-type mice, and immunoprecipitated with the antibodies against
C/EBPa, C/EBPb, Mash1 or NeuroD. We detected an association between all these
proteins and the c-fos promoter. Amplified products were also detected in parallel
immunoprecipitations performed in the presence of the antibody anti Histone-3 and its
acetylated form (figure 13B), but no products were detected in the absence of antibody
(figure 13B). These results suggest that Mash1, NeuroD, and either C/EBPa or C/EBPb
are constitutively present on the c-fos promoter.
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Figure 13 C/EBPs-Mash1, C/EBPs-NeuroD complexes are constitutively present on the c-fos promoter.
(A) In vivo detection of promoter occupancy by Mash1 and NeuroD using UV-crosslinking. Cortical
neurons from wild-type mice were either left unstimulated or stimulated with BDNF for 1 hour. Nuclear
extracts were incubated with a labeled oligo (2000000 cpm) containing the E-box motif in the contest of the
c-fos promoter, followed by UV-crosslinking. Immunoprecipitations were performed with anti-Mash1
antibody and anti-NeuroD antibody. As a negative control (NE) the reaction was performed without nuclear
extracts. Autoradiography revealed the presence of Mash1 and NeuroD on the c-fos promoter in a BDNF-
independent manner.
(B) In vivo detection of promoter occupancy by C/EBPs, Mash1 and NeuroD using chromatin
immunoprecipitation. Scheme for the c-fos promoter examined in this study. Bs represents the region
containing the different binding sites, the small arrows indicate the primers used in PCR amplifications, and
the large arrow represents published major transcription start site. Soluble chromatin was prepared from
entire forebrain of wild-type mice and immunoprecipitated with the diverse antibodies against C/EBPa,
C/EBPb, Mash1 and NeuroD. Control reactions lacking antibodies (NO Ab) and immunoprecipitation with
anti-Histone3 (H3) and anti-acetyl-histone3 (Ac-H3) antibodies are also shown.
The final DNA extractions were amplified using pairs of primers that cover the region of the c-fos gene
promoter as indicated. Input corresponds to PCR reactions containing 0.5% of the total amount of
chromatin used in immunoprecipitation reactions, and the lane NC is PCR without template. The
experiment was repeated three times, and gave very similar results.
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2.7 BDNF induces the phosphorylation of Thr188 in C/EBPb.
Given these results, it appears that BDNF may regulate gene expression through the post-
translation modification of transcription factors. Support for this idea comes from the
finding that ERK1/2 phosphorylate C/EBPb on Thr188 (mouse sequence) to activate its
transcriptional ability (Nakajima et al., 1993). Moreover, ERK1/2 is one of the major
pathways activated by TrkB (Kaplan and Miller, 2000). We therefore asked whether
C/EBPb is phosphorylated at the ERK1/2 site in cortical neurons following BDNF
treatment. As shown in figure 14A-E, after 15’ of BDNF stimulation phosphorylated
Thr188 form of C/EBPb was observed throughout the cell bodies of cortical neurons in
trkB+/+ (A-B). Nuclear localization of the pC/EBPb  signal was demonstrated by double
immunofluorescence staining with an anti-Thr188pC/EBPb antibody and DAPI (figure
14G-I). Interestingly, we observed an absence of colocalization on pericentromeric
heterochromatin.
Together, our data support the idea that the phosphorylation of C/EBPb by ERK1/2 is
responsible for the transcriptional activation of the C/EBP-Mash1and C/EBP-NeuroD
complexes downstream BDNF/TrkB.
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Figure 14 Analysis of activation and chromatin localization of C/EBPb in cortical neurons.
(A-E) BDNF induces the phosphorylation of Thr188 of C/EBPb. BDNF stimulation after 15’ induced
pC/EBPb signal  throughout the cell body of cortical neurons in trkB+/+ (A-B).
(C-E) Chromatin localization of pC/EBPb after BDNF stimulation. Primary cortical neurons from trkB+/+
mice were stimulated for 15’ with BDNF and subsequently double stained for pC/EBPb  (C) and DAPI
(D). An overlay revealed absence of colocalization between pericentromeric heterochromatin and
pC/EBPb (E) .
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2.8 Generation of mGif/TIEG1 mutant mice
In order to determine the function of mGif/TIEG1, we decided to delete the gene in vivo
using gene targeting. Since we did not know whether the deletion of this gene would be
lethal we generated two different types of targeted alleles: a null allele and a conditional
allele.
2.8.1 Isolation of the mGif/TIEG1 mouse genomic DNA
Microarray analyses revealed an up regulation of a cDNA homologous to exon 4 of
mGIF. An EST containing this exon (IMAGE ID 876145) was obtained from RZPD.
After amplification the clone was confirmed by sequencing and the plasmid (pT7T3D-
Pac mod1) was digested with EcoRI and NotI to release a fragment of 1434 bp. This
fragment was used to screen a genomic library by hybridization from IncyteGenomics.
Four BAC (pBeloBAC11 vectors) clones were obtained. The four clones were digested
with different enzymes and compared with mouse genomic DNA by southern blot
analysis using the same probe that was used for the library screening. An EcoRI digestion
identified a similar band of 12 kb in the genomic DNA and in the four clones. The
CELERA confirmed the presence of two EcoRI sites at 12 kb that surrounded the mGif
gene.
2.8.2 Targeting of mGif/TIEG1 gene via homologous recombination
2.8.2.1 Knock-out strategy
In order to inactivate the mGif/TIEG1 transcription factor, its third exon was deleted
thereby eliminating a region containing two zinc fingers which are fundamental for its
interaction with DNA (Fautsch et al., 1998). To achieve this, a targeting vector was
constructed using part of the isolated mouse genomic DNA and ET-recombination
strategy (Angrand et al., 1999). The final targeting vector contained: a long arm of 5978
bp, followed by a stop codon, an IRES-LacZ-polyA cassette, a blaP-Sve-neo-polyA
cassette, flanked by loxP sites, and a short arm of 2732 bp (figure 15A).
IB10/C mouse embryonic stem (ES) cells were electroporated with a Xho linearized
targeting vector, and cultured in medium containing selection agent (G418). Two
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hundred clones, resistant to G418 were isolated and screened by southern blot analysis.
After EcoRI digestion, four clones showed a mutant band of 8.9 kb and wild-type band of
12 kb, as revealed using probe 1, and a 4.7kb mutant band using probe 2 (figure 15B).
These results confirmed that in these four clones homologous recombination occurred,
that is, the third exon, 913 bp long, and the neighboring intron of 450 bp, were replaced
with a neomycin (neo) cassette, placed in the opposite transcriptional orientation, and an
IRES followed by a LacZ cassette.
2.8.2.2 Conditional strategy
We flanked (floxed) the second and third exon of mGif/TIEG1 with two loxP sites by
homologous recombination in ES cells. The targeting vector used contained a long arm of
6.9 kb followed by blaP-Sve-neo-polyA cassette, in the opposite orientation to the
mGif/TIEG1 gene and flanked by FRT sites, and a short arm of 2.7 kb (figure 16A). The
neo selection marker will be excised in vivo by crossing these mice with transgenic mice
expressing the Flp recombinase (Minichiello et al., 1998). In this way the expression of
mGif/TIEG1 should not be reduced due to the presence of the neo cassette.
IB10/C mouse embryonic stem (ES) cells were electroporated with an EcoRI linearized
targeting vector, and cultivated in medium containing selection agent (G418). Two
hundred clones, resistant to G418, were isolated and screened by southern blot analysis
using the same two probes, as for the null-allele screening. After EcoRI digestion, two
clones showed a mutant band of 14kb and wild-type band of 12kb using probe 1 and a,
14kb band, corresponding to a mutant allele, using probe 2 (figure 16B).
These results confirmed, that in these two clones homologous recombination had
occurred and that the mGif/TIEG1 wild type allele was properly replaced with the
targeted allele.
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Figure 15 Targeting of the mGif/TIEG1 transcription factor for the null allele.
(A) Schematic drawings of the wild-type mouse mGif/TIEG1 locus (wild-type allele), of the targeting
vector and of the mouse mGif/TIEG1 locus after genomic targeting (targeted allele). Grey vertical boxes
represent the exons. A 1.3 kb genomic DNA fragment was deleted in the targeting. The 6 and 2.7 kb DNA
fragments, corresponding to the long and short arm of the targeting vector, are located upstream and
downstream, respectively, of the neo and LacZ cassettes. The transcription of the neo cassette is in the
opposite orientation to the mGif/TIEG1 gene (arrows). Putative crossing-over between the wild-type
mGif/TIEG1 allele and the targeting vector are indicated by crossed dashed lines. In the targeted allele, the
DNA derived from the targeting vector (red) is distinguishable from the upstream and downstream genomic
DNA (black dashed lines).  Cleavage sites for restriction endonuclease, EcoRI and XhoI, are indicated.
Probes used to screen the ES cell clones are indicated with blue lines; probe 1 maps in the genomic DNA
sequence, upstream of the long arm, while probe 2 maps in the neo cassette.
(B) Southern blot analysis of genomic DNA from wild-type and two recombinant ES cell clones. The
recombinant ES clones, indicated with numbers 1 and 2, show specific bands of  8.9 kb with the probe 1,
and 4.7 kb with the probe 2. The wild-type clones are indicated with numbers 3 and 4.
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Figure 16 Targeting of the mGif/TIEG1 transcription factor for the conditional allele.
(A) Schematic drawings of : the wild-type mouse mGif/TIEG1 locus (wild-type allele), the targeting
vector, the mouse mGif/TIEG1 locus after genomic targeting (targeted allele +neo), the mouse
mGif/TIEG1 locus after deletion of the neo cassette in vivo using deleter-flp mice (targeted allele -neo), the
mouse mGif/TIEG1 locus after deletion of  the second and the third exon using specific CRE mice (tissue
specific recombinant allele). Grey vertical boxes represent the exons. A 1.8 kb genomic DNA fragment was
flanked by loxP sites in the targeting. The 6.9 and 2.7 kb DNA fragments, corresponding to the long and
short arm of the targeting vector, are located upstream and downstream, respectively, of the neo cassette.
The transcription of the neo cassette is in the opposite orientation to the mGif/TIEG1 gene (arrows), and it
is flanked by FRT sites. Putative crossing-over between the wild-type mGif/TIEG1 allele and the targeting
vector are indicated by crossed dashed lines.(next page)
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2.8.3 Generation of mutant mice for the mGif/TIEG1 transcription factor
Two of the targeted ES clones, for each construct, were microinjected into C57BI/6J
blastocysts and transferred into the uteri of pseudopregnant CD1 recipient mothers. For
the null allele fifteen chimeric mice were obtained, displaying partially agouti coat
colour, derived from the IB10/C ES cells, and partially black coat colour, derived from
the C57BI/6J blastocysts. For the conditional allele eight chimeric mice were obtained,
three of which were completely (100%) agouti in colour. Breeding of chimeras with
black wild type C57BI/6J mice, revealed the capacity of the chimeras to trasmit the
targeted allele to the progeny. This was easily established by looking at the coat colour of
the offspring, since only agouti pups have the potential to be either wild-type or
heterozygous for the mGif/TIEG1 mutation. The screening of the agouti mice is on
going.
In the targeted alleles and in the tissue specific recombinant allele, the DNA derived from the targeting
vector (red) is distinguishable from the upstream and downstream genomic DNA (black dashed lines).
Cleavage sites for restriction endonuclease, EcoRI and XhoI, are indicated. Probes used to screen the ES
cell clones are indicated with blue lines; probe 1 maps in the genomic DNA sequence, upstream of the long
arm, while probe 2 maps in the neo cassette.
(B) Southern blot analysis of genomic DNA from wild-type and recombinant ES cell clones. The
recombinant ES clone, indicated with number 1, shows specific bands of  14 kb with both probe 1 and
probe 2. The wild-type clones are indicated with numbers 2 and 3.
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Four major conclusions can be drawn from the data presented in this thesis. First, these
studies demostrate that BDNF, through TrkB receptor, induces the expression of a group
of transcription factors with similar kinetics in cortical neurons isolated at the peak of
neurogenesis. Second, using the c-fos promoter as a model, our data suggest that C/EBPs
and bHLH transcription factors collaborate to induce the activation of c-fos downstream
of BDNF. Third, in vivo and in vitro experiments indicate that bHLH proteins, Mash1
and NeuroD, bind C/EBP transcription factors at different domains. Finally, our studies
suggest that the formation of C/EBP-Mash1 and C/EBP-NeuroD complexes and their
occupancy of the c-fos promoter, are BDNF independent, but that BDNF regulates gene
expression by inducing post-translational modification of these complexes. In fact BDNF
stimulation was found to induce an increase in C/EBPb phosphorylation on Thr188,
which is ERK1/2-dependent, suggesting that activation of ERK1/2 could be one of the
possible mechanisms by which C/EBP-Mash1 and C/EBP-NeuroD complexes are
transcriptionally activated downstream BDNF/TrkB.
Together these data reveal novel nuclear targets of neurotrophin signaling cascades that
mediate gene expression in response to BDNF/TrkB activation in cortical neurons
isolated at the peak of neurogenesis.
3.1 A new role for BDNF during neurogenesis
Previous work has clearly demonstrated that intrinsic genetic mechanisms play an
essential role in regulating precursor cell survival, proliferation, and subsequent
differentiation into neurons or glia. These intrinsic programs, however, are heavily
influenced by environmental determinants such as growth factors (Shen et al., 1998),
(Lillien, 1998)
At least two members of the neurotrophin family, BDNF and neurotrophin-3 (NT-3),
along with their preferred tyrosine kinase receptors, TrkB and TrkC respectively, are
expressed in the cortical ventricular/subventricular zones at the onset of cortical
neurogenesis (Fukumitsu et al., 1998; Maisonpierre et al., 1990) and recent evidence
suggest that they function in regulating cortical progenitor cell biology. BDNF and NT3
are believed to promote survival and neurogenesis of cortical progenitor cells through
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two distinct and separable signaling pathways: the PI3-kinase pathway mediates survival,
while the MEK pathway is important for neurogenesis (Barnabe-Heider and Miller,
2003). Neurotrophins have also been shown to play an essential role in postmitotic
cortical neurons by regulating the survival, growth, phenotype, and ultimately,
connectivity of these cells (Kaplan and Miller, 1997; Kaplan and Miller, 2000). It is still
unclear, however, which transcription factors are activated by neurotrophins during
neurogenesis, and are responsible for inducing the gene expression necessary to mediate
these cellular changes. Data presented here provide some insight, by revealing that, with
respect to the activation of the c-fos promoter, one of the neurotrophin family members,
BDNF, acting through its high affinity receptor tyrosine kinase TrkB, requires
transcription factors known to be directly involved in neuronal differentiation processes.
The importance of this mechanism in vivo during neurogenesis remains unclear. In fact,
in contrast to the peripheral nervous system, in which single neurotrophins play essential
roles in regulating the biology of specific neuronal populations, such as NGF for
sympathetic  neurons (for review, see(Klein, 1994; Snider, 1994), multiple neurotrophins
appear to play redundant and overlapping roles in neurons of the central neurvous system.
It is likely that this functional overlap between neurotrophins, and potentially also with
other receptor tyrosine kinase ligands, such as FGF2, explains the relatively modest
phenotypes observed in the developing cortex of single neurotrophin knock-out animals
(Jones et al., 1994; Kahn et al., 1999; Ringstedt et al., 1998). Support this idea is derived
from studies of animals lacking both TrkB and TrkC, who display numerous CNS
abnormalities (Alcantara et al., 1997; Lotto et al., 2001; Martinez et al., 1998;
Minichiello and Klein, 1996; Ringstedt et al., 1998; Xu et al., 2000).
3.2 The shc-site and plcg-site of the TrkB receptor activate the same set
of transcription factors in primary cortical neurons isolated at the peak
of neurogenesis
We have examined mutant mice carrying signaling point mutations in the TrkB receptor
using two approaches, microarray and promoter analysis, and discovered that the shc-site
and plcg-site mediate the majority of signaling following receptor activation, and that in
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the absence of both sites gene expression is minimally activated by BDNF. Signalling
pathways downstream of the shc-site and the plcg-site also appear to activate the same set
of transcription factors in primary cortical neurons isolated at the peak of  neurogenesis.
Thus, the two sites could compensate for each other, although there is a higher activation
of gene expression in the plcg-point mutant mice compared to the shc-point mutant mice.
This could be explained by the possibility that the plcg-site mediates the induction of not
only positive regulators of gene expression, but also negative regulators, depending upon
the presence of other extrinsic factors and/or the developmental or functional status of the
cell. Therefore, in the absence of the plcg-site the balance between activation and
inhibition of gene expression downstream BDNF/TrkB may be disturbed, thus we
observe an overall increase in gene expression. This type of negative regulation has been
demonstrated for other signaling pathways. SOCS proteins (suppressors of cytokine
signaling) for example, are cytokine-inducible proteins and in turn downregulate the
same cytokine- activated JAK/STAT signaling pathway (Starr et al., 1997). An additional
reason for the increased activation of gene expression in the plcg-mutants may be through
TCF. We found that the activation of TCF downstream BDNF/TrkB is solely dependent
on signaling from the shc-site. Therefore the shc-site mediates an additional pathway
leading to gene expression that does not exist downstream the plcg-site. One way to test
these hypotheses would be to identify other as yet unknown, proteins that are downstream
of these two sites of TrkB, and whose functions could explain the difference in gene
expression observed in the two signaling point mutant mice.
Having identified c-fos, Egr1 and mGif as a group of transcription factors whose
expression in cortical neurons is similarly regulated by BDNF/TrkB at the time of
neurogenesis, it is reasonable to assume that these genes play a role during neurogenesis.
Although all these genes have previously been shown to be express in the central nervous
system their function during cortical development is unclear. A role for c-fos in the
differentiation of other cells types, however, has been described. Stable expression of c-
fos in mice, for example, is found in developing bones and teeth, hematopoietic cells,
germ cells, and neurons of the CNS. In the knockout model (Johnson et al., 1992; Wang
et al., 1992) mice displayed growth-retardation, osteopetrosis with deficiencies in bone
remodeling and tooth eruption, and as idiret effect an altered hematopoiesis. In addition,
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it has been shown that fos mutant mice that develop osteopetrosis have a block in the
differentiation of hematopoietic cells into bone-resorbing osteoclasts, which normally
occurs through an intrinsic programme (Grigoriadis et al., 1994). Although it is clear,
from both in vitro and in vivo studies, that c-fos is important for differentiation of
osteoclasts, in the CNS the only described role for c-fos has been in the regulation of
cellular mechanisms that mediate neuronal excitability and survival (Zhang et al., 2002).
In Drosophila, Sanyal et al. recently analyzed the cellular function and regulation of the
immediate early transcription factor AP-1, a heterodimer of the basic leucine zipper
proteins FOS and JUN, and observed that AP-1 functions upstream of CREB to control
synaptic plasticity by regulating synaptic strength and synapse number (Sanyal et al.,
2002). Similar to c-fos, Egr1 has also been reported to play a role in the CNS.
Inactivation of Erg1 in the central nervous system revealed its requirement for the long
term, but not short term synaptic plasticity in the dentate gyrus (Jones et al., 2001). The
results presented in this thesis extend our knowledge by revealing the presence of c-fos,
Egr1 and mGif downstream BDNF/TrkB in primary cortical neurons isolated at the peak
of neurogenesis.
3.3 Are C/EBPs determination or differentiation factors for cortical
progenitors?
The C/EBP family of transcription factors have been shown to function as regulators of
cellular differentiation in a number of different cell types, including hepatocytes,
mammary epithelial cells, ovarian luteal cells, keratinocytes, neuronal cells and intestinal
epithelial cells (Chandrasekaran and Gordon, 1993; Cortes-Canteli et al., 2002;
Lekstrom-Himes and Xanthopoulos, 1998; Robinson et al., 1998; Seagroves et al., 1998;
Sterneck et al., 1997; Zhu et al., 1999). Their role in mediating cell differentiation have
been best characterized, moreover, during the processes of hematopoiesis and
adipogenesis. Four members of the family (a, b, d and e) are expressed in myeloid cells
and show a unique expression profile during in vitro myeloid-cell differentiation
(Morosetti et al., 1997; Natsuka et al., 1992; Scott et al., 1992; Yamanaka et al., 1997b).
For example, the expression of C/EBPa is constant in the bone marrow-derived cells and
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decreased in polymorphonuclear neutrophils (Bjerregaard et al., 2003). Conversely, the
myeloid-restricted member, C/EBPe, is preferentially expressed during granulocytic
differentiation (Morosetti et al., 1997; Yamanaka et al., 1997b), whereas C/EBPb is up-
regulated during macrophage differentiation (Natsuka et al., 1992). The most compelling
evidence that C/EBPs are crucial for myeloid-cell differentiation and maturation has
come from studies on knockout mice. C/EBPa deficient mice fail to undergo myeloid
differentiation beyond the myeloblast stage, and therefore, lack neutrophil granulocytes,
and eosinophils (Zhang et al., 1997). C/EBPe deficient mice, on the other hand, fail to
produce atypical neutrophils,(Yamanaka et al., 1997a). Finally, the phenotype of C/EBPb
deficient mice indicates a potential role for this gene in the activation of macrophages as
well as in Th1 immune responses (Poli, 1998; Screpanti et al., 1995; Tanaka et al., 1995).
The importance of the C/EBP family in adipocyte differentiation has been confirmed
using a number of approaches. First, ectopic expression of C/EBPa and C/EBPb in 3T3-
L1 cells is able to initiate the differentiation programme in the absence of adipogenic
hormones, whereas overexpression of C/EBPd  accelerates the process triggered by these
agents (Freytag et al., 1994; Lin and Lane, 1994; Yeh et al., 1995). Second, expression of
antisense C/EBPa RNA in 3T3-L1 cells blocks differentiation (Lin and Lane, 1992).
Third, embryonic fibroblasts lacking both C/EBPb and C/EBPd are unable to initiate the
differentiation programme in response to hormonal stimulation (Tanaka et al., 1997).
Finally, C/EBPa deficient mice have dramatically reduced lipid accumulation in the
adipose tissue (Wang et al., 1995).
During these processes, various members of the C/EBP family have been shown to act in
concert with cell type-specific determination signals to promote or repress the
transcription of genes essential for cell differentiation, and as a result have been classified
as lineage instructive transcription factors (Freytag et al., 1994; Nerlov et al., 1998;
Radomska et al., 1998). For example the induction of eosinophil lineage commitment by
C/EBPb appears to be caused by its ability to down-regulate the expression of the Friend
of GATA (FOG) protein, allowing cooperative activation by C/EBP proteins and GATA-
1 (Querfurth et al., 2000). Also the activation of chromatin-embedded myeloid genes in
heterologous cell types, such as fibroblasts, has been accomplished by a combination of
Myb and C/EBP transcription factors (Burk et al. 1993;Ness et al. 1993), and this has
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been shown to involve the recruitment of the SWI/SNF chromatin-remodeling complex
by the N-terminal CR1 region of C/EBPb  (Kowenz-Leutz and Leutz, 1999). Finally,
Pedersen et al. have also shown that the ability of the C/EBPa  transcription factor to
direct adipocyte differentiation of uncommitted fibroblast precursors and to activate
SWI/SNF-dependent myeloid-specific genes both depend on the transactivation element
III (TE-III), domain of C/EBPa  which binds the SWI/SNF chromatin remodeling
complex. TE-III collaborates with C/EBPa TBP/TFIIB interaction motifs during the
induction of adipogenesis and adipocyte-specific gene expression (Pedersen et al., 2001).
Again these results indicate that C/EBPs   can  act as lineage-instructive transcription
factors through SWI/SNF-dependent modification of the chromatin structure of lineage-
specific genes, followed by direct promoter activation via recruitment of the basal
transcription–initiation complex. Together these findings suggest that C/EBPa/b function
as determination factors for multiple cell lineages.
In the current study we used the well-characterized c-fos promoter as a model to
understand which transcription factors are important for BDNF-dependent gene
expression. The c-fos promoter analysis we performed clearly demonstrates the
importance of the E-box and C/EBP binding site for the activation of c-fos downstream
BDNF, suggesting that C/EBPs and bHLH transcription factors might collaborate to
induce the activation of this promoter downstream of BDNF/TrkB during neurogenesis.
This notion is further supported by the identification of complexes that exist between
bHLH and C/EBP transcription factors bound to the c-fos promoter.
Given these current findings it is not clear whether C/EBPs act as determination factors in
conjunction with bHLH transcription factors in cortical progenitors to induce the
formation of neurons versus glial cells. Menard et al. have recently shown that the
inhibition of C/EBP activity biases cortical progenitor cells to remain as progenitors
instead of giving rise to neurons. Conversely, inhibition of C/EBP-dependent
transcription enhances CNTF mediated generation of astrocytes from the same progenitor
cells (Menard et al., 2002). These results have led Menard et al. to propose that in cortical
progenitors, C/EBPs act not as “determination” factors in the same sense as bHLHs like
the neurogenins, but as differentiation factors, responsible for initiating the transcription
of early neuronal genes in response to growth factor cues. In their model, progenitor cells
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are partially biased to become neurons as a consequence of the repertoire of bHLHs that
they express, and the growth factor-mediated activation of C/EBPs provides the final
“push” to trigger expression of a neuronal phenotype through the transcription of genes,
such as T1a-tubulin. Therefore, expression of the appropriate bHLHs would be a
requisite for the neurogenic actions of the C/EBPs; such necessary cooperativity with cell
specific determination factors, would allow C/EBPs to function as growth factor-
regulated differentiation signals in a variety of different cell types. In this sense, with
regard to their proneurogenic activities, the C/EBPs act neither as classic differentiation
or fate signals, but as necessary cofactors for fate-biasing molecules such as the bHLHs.
However, based on the data of Menard et al. it is possible that C/EBPs act as
determination factors, since in their absence the authors report an absence of
neurogenesis. In our study we show that C/EBPs bind bHLH transcription factors, and in
this way may collaborate to determine the fate of cortical progenitors. More study is
therefore necessary to determine the precise function of C/EBPs in the CNS, that is,
whether they are required for cell determination or differentiation.
3.4 How might the C/EBPs collaborate with the neurogenic bHLHs to
generate a postmitotic neuron?
We have now demostrated that in neurons, C/EBPa and b bind two members of two
different classes of bHLH transcription factors, the early differentiation factor Mash1,
and the late differentiation factor NeuroD. The identification of both Mash1-C/EBP and
NeuroD-C/EBP complexes, in our cell culture, is probably due to the fact that they
contain a mixed population of neurons at different stages of differentiation. Moreover, the
RT-PCR data presented here also indicate that C/EBPa, b, Mash1 and NeuroD are all
expressed in cultured cortical progenitors from E12 to E18, in which, both progenitors
and neurons are likely to be present. In vivo it has been shown that Mash1 and NeuroD
are expressed at different times and in different places of the telencephalon (Nieto et al.,
2001), suggesting that the complexes we have identified occur in different cells. Taken
together, we conclude that C/EBPs are expressed during neurogenesis, and are able to
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cooperate with cell specific neurogenic bHLHs.
Do the C/EBPs also play a role in regulating terminal mitosis as progenitors become
neurons? Although our data do not directly address this issue, C/EBPs have been
implicated in growth arrest in nonneural cells, an effect that they mediate at least partially
via the pRb family of proteins which are essential for cortical progenitor differentiation
into neurons (Slack et al., 1996; Slack et al., 1998). Given these findings, Menard et al,
have suggested that interactions between the C/EBPs and pRb family could provide an
integral link between terminal mitosis and the induction of the neuronal phenotype in
cortical progenitor cells. Based on our findings, we can suggest an additional possibility,
that C/EBPs directly interact with different bHLH factors at different stages of
differentiation: specific interactions at an early phase induce the differentiation process,
whereas interactions with different bHLHs at a later phase activate the gene expression
necessary for terminal cell differentiation. In fact we find that Mash1, an early
differentiation factor, interacts with the N-terminal region of C/EBPa, in which resides
its anti-mitotic effect (Lin et al., 1993; Umek et al., 1991), whereas NeuroD, a late
differentiation factor, interacts with the C-terminal region of C/EBPa and b and that
interaction is impaired by mutations in highly conserved residues in the non-DNA
binding face of the basic region. Porse et al  have shown in mice that mutations in the
basic region of C/EBPa are defective in repressing E2F-dependent transcription, and fail
to support adipocyte and granulocyte differentiation in vivo (Porse et al., 2001). If bHLH
and E2F proteins bind C/EBPa in the same regions, it is possible to have a competition
for the C/EBPa  binding by these two proteins. C/EBPa  interaction with E2F represses
the expression of E2F-dependent genes, which are genes known to stimulate cell cycle
progression and/or inhibit differentiation. Conversely, C/EBPa , binding to bHLH
proteins, induces the expression of genes involved in cell differentiation. Therefore it is
through multiple pathways that C/EBPa  likely  promotes cell differentiation.
3.5 How does BDNF control the transcriptional activity of the complexes
formed between bHLHs and C/EBPs?
From our studies it is clear that BDNF regulates neither the formation of Mash1-C/EBP
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and NeuroD-C/EBP complexes, nor their translocation onto the promoter of genes that
are regulated by BDNF. BDNF induction of the c-fos promoter, however, is low in the
absence of the C/EBP binding site and E-box, suggesting that BDNF/TrkB signaling may
influence the transcriptional activity of these complexes by inducing their post-
translational modification.
For the bHLH transcription factors, little is known about the regulation of their
transcriptional activity by post-translational modification. The activity of C/EBPb,
however, is known to be regulated through their direct phosphorylation of ERK1/2 at
Thr188 (Nakajima et al., 1993; Williams et al., 1995) and by Rsk, which can itself  be
induced by ERK1/2, one of the major and well-characterized kinase pathway downstream
of tyrosine kinase receptors (Davis, 1995). Thus, these receptors may signal to activate
the C/EBPs via several parallel signaling cascades, one of which involves the
Raf/RAS/MAPK pathway. In neurons, Menard et al have shown that phosphorylation of
C/EBPb at the Rsk site (Thr217) is sufficient to enhance neurogenesis. Through this same
mechanism, both FGF2 and PDGF have been shown to activate C/EBPs in osteoblasts
(Wadleigh and Herschman, 1999), and a MEK-ERK-Rsk- C/EBPb  pathway has recently
been implicated in the control of hepatocyte apoptosis in response to TGFa (Buck et al.,
2001). Data presented here indicate that during neurogenesis BDNF can activate the
C/EBP family via MEK-ERK1/2 phosphorylation of Thr188.
In conclusion, the present study implicates the ERK-C/EBP pathway as a novel growth
factor regulated signaling cascade, that promotes the genesis of neurons from neural
precursors in response to BDNF/TrkB activation. We propose that this pathway provides
an intracellular mechanism for integrating and coupling diverse growth factor stimuli to
the intrinsic cellular machinery, thereby ensuring that neurons are generated in
appropriate numbers at the appropriate time during development.
3.6 Future directions
 To verify the role of C/ EBPs in neurogenesis it would be necessary to develop a mouse
model in which at least two C/EBP family members are eliminated from the CNS (to
avoid redundancy) and examine the effects on neuronal differentiation.
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The expression patterns of the members of this family often overlap, making it difficult to
discern the specific regulatory functions of each protein. Mice carrying single gene
deletions of C/EBPa and b do not display any phenotype in the CNS. Mice lacking
C/EBPa die shortly after birth due to hypoglycemia and an absence of stored glycogen in
the liver (Wang et al., 1995). Mice deficient for C/EBPb are viable but display immune
defects, (Screpanti et al., 1995; Tanaka et al., 1995) and female sterility (Sterneck et al.,
1997). To overcome these problems, and to address the role of C/EBPs in the CNS, it
would be best to create a mouse model with a null deletion of C/EBPb, and conditional
deletion of C/EBPa  in the CNS. Once created these mice should be specifically
examined for defects in the differentiation of GABAergic populations, which is predicted
to require a C/EBP association with Mash1, and of principal neurons, which require
NeuroD function. The results of such analyses would reveal whether C/EBPs are required
for determining the fate or differentiation of these cell types.
3.7 mGif/TIEG1 transcription factor: new target for BDNF/TrkB
The function of mGif/TIEG1 has been studied only in vitro, so to better understand the
function of this gene we decided to generate the null and conditional alleles of
mGif/TIEG1 in mice. mGif/TIEG1 is widely expressed and is present at least at E16.5
(Yajima et al., 1997). Given its early onset of expression, it is possible that a complete
deletion of mGif/TIEG1 is lethal, thus it was necessary to create the conditional allele.
Depending on the phenotype of the knock-out mouse, mice with conditional alleles will
be crossed with various CRE mice, in order to study the role of mGif/TIEG1 in specific
tissues. During the gene targeting for the null allele we also introduced the LacZ cassette
in the genomic locus of mGif/TIEG1, which will also allow us to analyze the expression
pattern of the transcription factor.
It has been shown in vitro that mGif/TIEG1 acts as a tumor suppressor (Chalaux et al.,
1999; Hefferan et al., 2000; Ribeiro et al., 1999; Tachibana et al., 1997), so it is possible
the mutant mice will have a susceptibility to developing tumors, and might therefore be
used as a model for human disease.
DISCUSSION
64
In addition to be induced by BDNF, mGif/TIEG1 has also been shown to be induced by
GDNF. It would therefore be interesting to compare the phenotypes of the mGif-null
mice with strains lacking the gene for GDNF or BDNF to dissect the signaling pathways
that lead to its induction.
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4.1 Primary cultures of cortical progenitors and neurons
The preparation of cortical progenitors from mouse embryos was based on a previously
described method (Menard et al., 2002). Cortices were collected from E12-13 mouse
embryos, triturated, and then plated on poly-L-lysine (at different densities depending on
the final experiment). The culture medium consisted of Neurobasal medium (GIBCO
BRL), 0.5 mM glutamine, penicillin-streptomycin, 1% N2 supplement (GIBCO BRL),
and bFGF (40 ng/ml; R&D system). After 48 h, medium was replaced with the same
medium containing 2% B27 supplement (GIBCO BRL) instead of 1% N2 supplement.
The cortical neurons generated from these progenitor cells could be maintained for at
least 3 weeks under these conditions.
Mature postmitotic neurons were prepared from cerebral cortices of E15.5 mouse
embryos derived from intercrosses of wild type, trkBSHC/SHC, trkBPLC/PLC, trkBWT/WT
homozygotes. Cortical neurons were dissociated and plated onto poly-L-lysine
hydrobromide (Sigma) in the presence of 10% heat-inactivated horse serum which was
replaced to N2-MEM after 3 hr. Cells were cultured for an additional 16 hr prior to ligand
stimulation in N2-MEM medium (Minichiello et al., 1998) at 37°C in 5% carbon dioxide.
Purified recombinant BDNF (Genentech, Inc., and Regeneron Pharmaceuticals, Inc.) was
added to the culture medium at a concentration of 50 ng/ml at different time points.
4.2 Molecular biology
Standard protocols for molecular biology were taken from Molecular Cloning Laboratory
Manual (2nd edition). For DNA preparation: MiniPrep, QIAquick PCR purification and
Gel extraction kits (Qiagen) were used according to manufacturer instructions. For PCR
protocols, AmpTaq polymerase from Applied Biosystem was routinely used. Ligations
were performed using T4 DNA ligase from New England Biolabs. Restriction enzymes
were purchased from New England Biolabs. If not otherwise stated, E.Coli strain XL1-
blue was used.
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4.2.1 Plasmids
The pGL3-basic and pRSV-b-Gal vectors were obtained from Promega, while the
pBluescript II KS+ vector was obtained from Stratagene.
The following constructs: pMSRF/cebp, pMcebp/ebox, pMebox/AP1, pMebox, pMCRE
were constructed by digesting pFC700, as previously described (Ray et al., 1989), with
HindIII and XbaI to release a 753-bp fragment. This fragment, after a subcloning step in
pBluescript II KS+ vector, was inserted into KpnI-SacI digested pGL3-basic.
The different mutations were introduced using the QuickChange Site-Directed
Mutagenesis Kit, and the following mutagenic oligonucleotide primers:
pMebox/AP1:   tgtccatattaggacatccatggcagcaggtttccacggcc
pMebox:  tgtccatattaggaaatctgcgtcagcaggtttccacggcc
pMCRE:   ccgtggttgagcccgtgatgtttacactcattcat
pMSRF/cebp, pMcebp/ebox were kindly provided from C. Nerlov.
All C/EBPa derivatives were introduced in pcDNAI (Invitrogen) for in vitro labeling as
BamHI-EcoRI fragments. The basic region point mutants (BRM-1: V287A, E290A;
BRM-2: I294A, R297A; BRM3: D301A, K304A; BRM-5: Y285A) were introduced by
overlapping PCR using rat C/EBPa ,  and confirmed by DNA sequencing. All
C/EBPa derivatives were provided from C. Nerlov and described in Porse et al., 2001.
The GCN4 zipper exchange mutant (C/EBPa :Gz) has been previous described (Agre et
al., 1989). Full length C/EBPa :Gz was amplified by PCR from pC/EBPa :Gz using
primers BamHI/5’gcttggatccccatggagtcggccgacttc, and gaggaattcagcgttcgccaactaatttc
3’/EcoRI. The PCR product was cloned into the polylinker of pcDNAI using the BamHI
and EcoRI sites.
Mouse Mash1 full-length cDNA was obtained by RT-PCR using RNA isolated from
cortical neurons RNA by RT-PCR (GeneAmp kit from Applied Biosystem) and the
primers EcoRI/5’ggaattcccggcatggagagctc, and gctctagaggacggtcctcagaa 3’/XbaI. The
PCR product was cloned into the polylinker of pcDNA3 using the EcoRI and XbaI sites.
Mouse NeuroD full-length cDNA was obtained by RT-PCR using RNA isolated from
cortical neurons and the primers BamH1/5’cgggatccgtggaaacatgacc, and
ggaattcactgacgtgcctcta 3’/EcorI. The PCR product was cloned into the polylinker of
pcDNA3 using the BamH1and EcoRI sites.
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Rat Myogenin full-length cDNA has been previously described (Wright et al., 1989). The
full-length cDNA was obtained by cutting a myogenin cDNA containing pEMSV with
EcoRI, and was subcloned into the EcoRI sites of pcDNA3. The correct orientation was
checked by KpnI digestion.
4.2.2 Generation of mGIF/TIEG1 targeting constructs
The genomic BAC clone, containing the mGIF/TIEG1 transcription factor was obtained
by library screening (Incyte Genomics). Gene targeting was performed using both a
knock-out and a conditional-approach. An ET-recombination strategy was used to obtain
the targeting vectors (Angrand et al., 1999).The plasmids used for ET-recombination
were: plZKeoX1 (provided by F. Stewart), pSVKeoX1 (provided by F. Stewart), and
pSVKeoneoFLP, which was derived from pSVKeoX1 by the insertion of  two FRT sites
and the elimination of one loxP site (provided by B. Porse). The bacterial strain for the
recombination was JC8679 (Angrand et al., 1999).
The targeting vector for the knock-out consisted of a long arm of 5978 bp, followed by a
stop codon at the beginning of exon 3 of the gene, an IRES-LacZ-polyA cassette, blaP-
Sve-neo-polyA cassette flanked by loxP sites, and short arm of 2732 bp.
The targeting vector for the conditional allele consisted of a long arm of 6891 bp, a blaP-
Sve-neo-polyA cassette, positioned in the opposite direction to the mGif/TIEG1 gene and
flanked by FRT sites, and a short arm of 2732 bp..
4.2.3 Targeting of mGif wild-type allele
The targeting vector (100 mg) for the knock-out allele was linearized with an XhoI
restriction endonuclease, while the targeting vector (100 mg) for the conditional allele
was linearized with an EcoRI restriction enzyme.
After linearization, 30 mg of DNA was electroporated into ES cells (107 cells) at 220V
and 480 mF in a Biorad Gene pulser. The cells were incubated for 20’ on ice and
subsequently plated on gelatine coated 10 cm dishes in ES medium. After 40 hr, selection
with G418 was begun and continued for 10 days. To identify the recombinant clones
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carrying the targeted allele, southern blot screening was carried out using an external
probe in the 5’ region and an internal probe in the neo cassette (describe below).
4.2.4 Isolation of DNA from ES clones and southern blot analysis
For screening of the ES cells, the confluent plates were washed with PBS. 50 ml of lysis
buffer (10mM Tris, pH 7.5; 10 mM EDTA pH 8, 10 mM NaCl 0,5% sarcosyl, 100 mg/ml
proteinase K) was added to each well and incubated ON at 550C. The DNA was
precipitated using 100 ml EtOH/NaCl, washed three times with 70% ethanol, dried and
digested with EcoRI ON at 370C. 18 ml of the ES DNA preparation was separated using
0.7% agarose gels, run at 30V for 15-18 hr.
Before blotting, the gels were stained with ethidium bromide, and then depurinated for
15’ in 0.25 M HCl, denaturated with 0.4 M NaOH, 2 times for 30’, and finally
neutralized with SSC 20X (NaCl 3M, C6H5Na3O7 0.3M) for 1 hr.
Gels were blotted ON onto a GeneScreen Plus membrane (Perkin Elmer)  in presence of
SSC 20X (capillary blotting). The membrane was baked at 800C for 1 hr and then washed
for 1 hr in 0.1X SSC and 0,5% SDS at 650C to reduce background. Prehybridization was
then performed for 2 hr at 420C (50% deionized formanide, 5X SSC, 5% denhart’s
solution, 50 mM Na3PO4 pH 7,2, 1% SDS 350 mg/ml DNA salmon sperm), followed by
hybridization with probe ON at 420C (50% deionized formanide, 5X SSC, 5% denhart’s
solution, 50 mM Na3PO4 pH 7,2, 1% SDS 100 mg/ml DNA salmon sperm, 5% destran
sulfate). The probes were prepared using Random Primed DNA Labeling Kit (Roche).
Probe 1 was 600 bp in length and was obtained by PCR using the following primers:
5’gacttaatttggctgtagga 3’
5’cccactcctcaagtccatcct 3’
Probe 2 was 700 bp and was obtained by digesting the plZKeoX1 vector with NcoI.
Following the hybridization, the blots the were washed in 2X SSC and 1% SDS, twice at
room temperature and once at 500C, and then washed in 0.1X SSC and 1%SDS, twice for
30’ at 550C. Hybridized probes were visualized using phosphoimager system.
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4.2.5 RNA isolation
Following BDNF stimulation cortical neurons were washed twice with cold PBS, and
then lysed in 1 ml of TRIzol (GIBCO Life Technologies). Homogenized samples were
incubated for 5’ at room temperature, then 200 ml of chloroform was added, the tubes
were shook by hand for 15” and then incubated for 3’ at room temperature. The samples
were centrifugated to separate the two phases. The upper phase was transferred to a fresh
tube and the RNA was precipitated by adding 500 m l of isopropanol, and by
centrifugation for 15’ at 15000rpm. The RNA pellet was washed once with 70% ethanol
and briefly dried. RNA yield was quantified by spectrophotometric analysis using the
convention that 1 absorbance unit at 260 nm equals 40 mg RNA per ml. The absorbance
was routinely checked to determine RNA purity. The A260/A280 ratio was close to 2.0.
To obtain a concentration of 2 mg/ml, different samples were pooled and precipitated by
adding 1/10 volume 3 M NaOAc, pH 5.2, and 2.5 volumes ethanol, and incubated at
–20oC for 1 hour. The samples were centrifugated at 12000rpm for 20’ at 4 oC, and the
pellet was washed with 70% ethanol. The pellet was air dried and resuspended in DEPC-
treated H2O. At this point the RNA was sent for Affymetrix analysis performed using
Murine Genome U74Av2 chips.
4.2.6 Northern blot
15 mg of RNA was dissolved in 4.5 ml of water plus: 3.5 ml of 37% formaldeide, 10 ml of
deionized formamide, 2 ml of MOPS 10X (MOPS 0.2 M, CH3COONa 50 mM, EDTA
5mM) and incubated 15’ at 55oC. 2 ml of RNA loading buffer (50% glycerol, 1 mM
EDTA, 0.4% bromophenolblue) and 2 ml of ethidium bromide (1 mg/ml) were added to
samples before loading on a formalin- 1.5% agarose gel, in 1X MOPS running buffer.
The gel was run at 100V for 3 hours. Before blotting the gel was soaked in water for 30’
and then in SSC 20X for 15’. The gel was blotted overnight onto GeneScreen Plus
(PerkinElmer) using 20X SSC. After blotting the membrane was UV-crosslinked using a
Stratalinker (Stratagene).
The probes for c-fos, Egr1 and mGif were obtained from ESTs by RZPD. The cDNA
fragments were purified by agarose gel and 20 ng for each of them were used for labeling
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using a Random Primed DNA Labeling kit (Roche). The blots were prehybridized at
42oC for 3 hr, and then hybridized ON at 42 oC using the same buffer (SSC 5X, 50%
deionized formamide, Denhart’s solution, 50 mM Na3PO4 1% glycine) containing
different concentration of DNA salmon sperm: 350 mg/ml in the prehybridiziation and
100 mg/ml in the hybridiziation buffer. Washes were performed first at room
temperature, and then two times for 10’ at 42 oC in SSC 1X and SDS 0,1%. The
membrane was then exposed to Biomax film at –80oC, ON.
4.3 Reporter gene assay
Cortical neurons were plated at 3x106 cells per 60-mm well. The transfections were
carried out on 3 or 4 DIV using Lipofectamine 2000 Reagent (Invitrogen) according to
the protocol supplied by the manufacturer. One 60-mm well of cells was transfected with
2.3 m g of reporter plasmid plus 3 mg of pRSV-b-gal. Twenty-four hours after
transfection, cells were left unstimulated or stimulated with 50 ng/ml BDNF for 2 hours.
The plates were then washed twice with cold PBS (137 mM NaCl, 2.7 mM KCl, 4.3 mM
Na2HPO47H2O, 1.4 mM KH2PO4) and the cells were lysed with 250 ml Triton lysis
solution (100 mM potassium phosphate, pH 7.8, 0.2% Triton X-100, 1 mM DTT). The
cell debris was removed by centrifugation, and the lysate was used in either a luciferase
or b-gal assay. Relative luciferase units were defined as the ratio of b-gal normalized
luciferase activity in lysates of stimulated cells relative to the normalized luciferase
activity from unstimulated cells.
4.3.1 Measuring luciferase activity
The luciferase activity was measured using a Lumat LB 9507 luminometer. The samples
were measured using 50 ml lysate in 350 ml reaction solution (25 mM Gly-Gly pH 7.8, 2
mM ATP, 10 mM MgSO4). 100 ml injection solution (25 mM Gly-Gly pH7.8, 0.2 mM
Luciferin) was injected in each reaction.
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4.3.2 Measuring b-gal activity
The b-gal activity was measured as follows: 0.4 ml ONPG (20mg/ml in ethanol) and 1.4
ml MeSH was added to 10 ml of the b-gal buffer (60 mM Na2HPO4, 40 mM NaH2PO4, 10
mM KCl, 1 mM MgCl2). 50 ml lysate was placed in a well on a 96 well plate and 150 ml
b-gal buffer was added and incubated at 37oC. The reaction was stopped with 50 ml 1 M
Na2CO3 and the absorbance was measured at 414 nm in an ELISA-reader.
4.4 Biochemistry
4.4.1 Nuclear extract preparation
Following treatment cortical neurons were washed twice with cold PBS, and then lysed
on ice for 10’ in buffer A (10 mM KOH-Hepes pH 7.9, 1.5 mM MgCl2, 10 mM KCl,
1mM DTT, PMSF 0.5 mM). Nuclei were collected by centrifugation at 13000 rpm for 1
min and then lysed in the buffer C (20 mM KOH-Hepes pH 7.9, 1.5 mM MgCl2, 417 mM
NaCl, 25% glycerol, 0.2 mM EDTA, 1 mM Dithiothreitol (DTT),
phenylmethylsulfonylfluoride (PMSF) 0.5 mM) for 20’ on ice. Insoluble material was
removed from nuclear extracts by centrifugation at 13000 rpm for 2’at 4oC.
4.4.2 Immunoprecipitation
Immunoprecipitations were performed by incubating 50 mg of nuclear extracts in buffer
C, with specific antibodies for 2 hr at 4oC. The antibodies used were the followed: 2 ml
goat anti-NeuroD (sc-1086X), 10 ml rabbit anti-Mash1 (provided by JE Johnson), 2 ml
14AA anti-C/EBPa (sc-61X; Santa Cruz Biotechnology), 4 ml C-103 anti-C/EBPa, 2 ml
C-19 anti-C/EBPb (sc-150X; Santa Cruz Biotechnology), 4 ml D198 anti-C/EBPb (sc-
746; Santa Cruz Biotechnology).
Precipitates were collected with Protein A-Sepharose or Protein G-Sepharose (Amersham
Pharmacia) for 1 hr at 4oC. The beads were washed three times in buffer C and the
protein was eluted on 20 ml of 2X SDS sample buffer incubated at 95oC for 5’. 10% SDS-
PAGE gels analyzed Immunoprecipitates. Protein blots were probed ON at 4oC with
specific antibodies, followed by incubation with a horseradish peroxidase-coupled
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secondary antibody, and analyzed using the ECL chemiluminescence system
(Amersham).
To test the interaction C/EBP-Mash1, C/EBP-NeuroD and C/EBP-Myogenin;
pCMVawt, pCMVaBRM1,  pCMVaBRM2,  pCMVaBRM3,  pCMVaBRM5, were
transcribed and translated using TNT T7 kit in the presence of unlabelled methionine, for
90’at 30oC. Instead, NeuroD, Mash1 and Myogenin were transcribed and translated in
vitro in the same way but in presence of 35S-methionine. After purification by Microcon
YM-10, the labeled proteins were incubated with the unlabeled proteins for 1 hr at room
temperature, and then immunoprecipitated in NP40 lysis buffer (20mM TRIS pH7.4,
140mM NaCl, 10% glycerol, 1% NP-40 and protease inhibitors) using 1 ml rabbit 14AA
anti-C/EBPa, as described above. The proteins were separated using 10% SDS-PAGE.
The gels were dried and subsequently exposed to film (BioMax MR-1 film, Kodak) for
12 hr at –70oC.
4.4.3 UV-crosslinking
50 mg of nuclear extract was incubated with polydI-dC for 15’ at room temperature.
2x106cpm of oligo containing the E-box motif of the c-fos promoter and 5Br-dU (Q) in
one strand (5’ gaggacatcQgcgtccc), was then added and left 20’ at room temperature,
followed the UV cross-linking in stratalinker (STRATAGENE) five times 5’ and in the
middle 5’on ice.
At this point the antibodies bound to the beads were added and incubated 2 hours at 4oC,
after the normal immunoprecipitation was performed. Mash1 and NeuroD were bound
covalently to protein-G beads using dimhetylpimelidate (Sambrook et al., 1989).
4.4.4 SDS-PAGE, Staining, Western Blot
Protein concentrations were determined using the Bio-Rad Dc protein assay (Biorad).
Proteins were usually analyzed on 1 mm thick minigels (Bio-Rad apparatus).
The tris-glycine separating gel contained 10% acrylamide (Bio-Rad, stock solution 30%
Acrylamide/bis-acrylamide 37.5:1 ratio), 375 mM Tris-HCl pH 8.8, 0.1% SDS, 0.1%
ammonium persulfate and 0.001% N,N,N’,N’-tetramethylenediamine (TEMED). The
stacking gel contained 4% acrylamide, 125 mM Tris-HCl pH 6.8, 0.1% SDS, 0.1%
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ammonium persulphate and 0.001% TEMED. The gels were run in Laemmli running
buffer (25 mM Tris base, 200 mM glycine, 0.1% SDS) at a current of 20-40 mA per gel.
Proteins were transferred onto Protran nitrocellulose (Schleicher & Schuell) using a
Hoefer SemiPhor apparatus for 1 hr at a constant mA (1mA/cm2 gel area) in transfer
buffer (20 mM Tris base, 150 mM glycine, 0.1% SDS, 20% methanol). Membranes were
stained in 0.2% Ponceau S solution (Serva) and then washed. Unspecific binding was
blocked by incubating membranes in 5% non-fat dry milk in PBS containing 0.1%
Tween-20 (BioRad) from 1 hr at room temperature.
Antibodies were diluted 1:1000 in PBS, 5% milk, 0.1% Tween-20, added to the blots,
and incubated ON at 4oC. After each antibody incubation the membrane was washed 3
times in PBS, 0.1% Tween-20 for a total of 30’. Horseradish peroxidase conjugated
secondary antibodies were used and ECL revealed the signal.
4.4.5 GST pull-down assay
In vitro pull down analysis was carried out using a fusion of: C-terminal of C/EBPb to
GST, 156-358 domain of C/EBPa to GST, 1-96 domain of C/EBPa to GST and unfused
GST (from pGEX4T-1; Pharmacia) (Nerlov and Ziff, 1995).
Mash1, NeuroD and Myogenin were 35S labeled and in vitro translated using pcDNA3 T7
expression vectors, the Promega TNT T7 coupled transcription/translation system and L-
35S-methionine (Amersham Biosciences). Bound 35S-labeled proteins were resolved by
SDS-PAGE.
4.4.5.1 Purification of GST fusion proteins
The GST-constructs were transformed into a competent BL21 E.Coli strain (Invitrogen)
carrying the plasmid pRI952 (Smithkline Beecham) and grown in 25 mg/ml
choloramphenicol and 100-mg/ml ampicillin.
A starter culture was incubated ON, then diluted 1:10 and grown 1.5 hr at 30oC. IPTG
was added to a final concentration of 0,1 mM and the cells were agitated for 3 hr at 30oC.
Cells were pelleted at 4500 rpm, washed in ice-cold STE (10 mM Tris pH 8, 150 mM
NaCl, 1 mM EDTA), resuspended in 7.5 ml STE with 1 mg/ml lysozime, and incubated
on ice for 15’. DTT to a final concentration of 5 mM, 1.25 ml 10% sarcosyl in STE, and
one complete mini protease inhibitor cocktail tablet (Boehringer), dissolved in 1 ml
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water, were added to the suspension. The suspension was vortexed and sonicated on ice.
After sonication, the cell debris was pelleted by centrifugation for 30’ at 16000rpm, and
the supernatant recovered. TritonX-100, at 2% final concentration, was added to the
suspension by vortexing.
Glutathione Sepharose 4B beads (Amersham) were washed in NETN (0.1 M NaCl, 1 mM
EDTA, 10 mM Tris pH 8, 0.5% NP40) and resuspended to a concentration of 50%. 200
ml of the bead suspension was added to the lysate and incubated 1 hr at 4oC on a wheel.
After incubation the beads were washed 3 times in ice-cold NETN and resuspended in
1ml NETN.
To estimate the relative protein contents of the beads, samples were run on a 12.5% SDS-
PAGE gel and coomassie stained (Sigma) according to the protocol supplied by the
manufacturer.
4.4.5.2 GST pull downs
Pull down reactions was carried out by preincubating 100ml of the bead suspension
(corresponding to about 500 ng protein) with 50ml 10% BSA and 350ml pull-down buffer
(50 mM Tris pH 8, 250 mM NaCl 0.5% NP40). The reaction was incubated with gentle
shaking for 30’ at room temperature before adding 5ml of 35S labeled in vitro translated
protein. The incubation was continued for 1 hr. After incubation the beads were washed 3
times with ice-cold NETN, pelleted and then 20ml of 2X SDS buffer (20% glycerol, 4%
SDS, 10% b-mercaptoethanol, 125 mM Tris-Cl pH 6.8, 0.2% bromophenol blue) was
added. The samples were boiled and the beads were pelleted. The supernatants were run
on 12.5% SDS-PAGE gels. The gels were dried and radio labeled protein was detected on
a Fuji BAS2040 phosphoimager.
4.5 ChIPs ANALYSIS
Adult mice were perfused with 10 ml of PBS followed by 5 ml of PBS with 1%
formaldehyde at 30oC. The forebrains were dissected from the animals and incubated
another 5’ in a 30oC oven. The reactions were stopped by placing the brains on ice in 10
ml of buffer A (15 mM Hepes, pH 7.6, 60 mM KCl, 15 mM NaCl, 0.2 mM EDTA, pH 8,
0.5 mM EGTA, pH 8, 0.34 M sucrose, 0.15 mM 2-mercaptoethanol, and 125 mM
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glycine) and mincing with small scissors. Crude nuclei were prepared by Dounce
homogenization and centrifugated at 4.000 rpm for 10’followed by a subsequent
centrifugation at 4000 rpm for 10’ in 1.5 ml of 1:1 buffer A: buffer B (15 mM Hepes, pH
7.6, 60 mM KCl, 15 mM NaCl, 0.1mM EDTA, pH 8, 0.1 mM EGTA, pH 8, 2.1 M
sucrose, and 0.15 mM 2-mercaptoethanol). Nuclei were resuspended in 5 ml of
sonication buffer (50 mM Tris, pH 8, 2 mM EDTA, pH 8, 0.5% N-lauroylsarcosine, 0.5
mM phenylmethylsulfonyl fluoride, 0.5 mg/ml leupeptin, 2 mg/ml aprotinin), then
incubated 5’ at room temperature, 5’ on ice, and sonicated with a Bondelin Sonoplus
GM200 sonifier mounted with a microtip for two 20-s pulses (duty cycle constant; output
40%). Cross-linked chromatin was separated in a CsCl step gradient (1 ml of 1.75 g/ml, 1
ml of 1.5 g/ml, and 1 ml of 1.35 g/ml CsCl in 0.5% N-lauroylsarcosine and 1mM EDTA,
pH 8) at 31000 rpm at 20 oC for 20 hr. Peak DNA-containing fractions, identified by
agarose gel electrophoresis and ethidium bromide staining, were pooled, treated with 25
ng/ml RNAse A for 2’ at 37 oC, and then dialyzed against Tris-EDTA (10 mM Tris, pH 8,
and 1 mM EDTA). The purified, cross-linked chromatin was aliquot and stored at -80 oC.
The cross-linked chromatin was dialyzed ON in RIPA buffer (50 mM Tris-Cl pH 7.5, 150
mM NaCl, 1% NP40, 0.5% DOC, 0.1% SDS). After a preclearing step with a salmon
sperm DNA/Protein A agarose Slurry (50% slurry Upstate), 100 mg of purified chromatin
was incubated ON at 4 oC, with rotation either alone or with 5 ml of rabbit antiserum
against Mash1, or 2 ml of rabbit antiserum against C/EBPa, C/EBPb, NeuroD (Santa
Cruz), or 2 m l histone H3 (Abcam), or 2 m l acetylated histone H3 (Upstate
Biotechnology). The immuno complex was collected with 60 ml of salmon sperm
DNA/Protein A Agarose Slurry for 1 hr at 4 oC with rotation. Bound material was
recovered by centrifugation at 2500 rpm for 2’, and immunoprecipitated products were
washed three times with 1 ml of RIPA buffer. 100 ml of Tris-EDTA was then added and
incubating at 68 oC for 3 hr reversed the crosslinking. To analyze the DNA, the material
was treated with proteinase K at 45oC, extracted with phenol:chloroform, and ethanol-
precipitated in the presence of 10 m g of the glycogen as carrier. The final
immunoprecipitated DNA products were resuspended in 20 ml of Tris-EDTA for PCR
analysis.
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Each PCR amplification was performed using 2 ml of the immunoprecipitated DNA in a
final volume of 50 ml using 50 pmol of each primer, 200 mM of each dNTPs, 1.5 mM
MgCl2, 1X PCR buffer (Applied Biosystem), 2.5 units of Taq DNA polymerase, and 2.5
% DMSO. The PCR conditions were: initial denaturation at 94oC for 5’, 30 cycles of
94oC for 30”, 58oC for 20”, 72oC for 10”; and final elongation at 72oC for 5’.
Amplification products were analyzed on 2.5% agarose gels. The PCR primers were:
5’gctgcaccctcagagttgg3’, 5’ccgtggaaacctgctgac3’.
4.6 Immunocytochemistry
Cortical progenitors derived from cerebral cortices of E12.5 mouse embryos were
stimulated after 6 DIV with 50 ng/ml of BDNF for 15’ at 37 oC. The cells were then fixed
in 4% PFA for 20’. Washes were performed with 10 mM PBS/glycine to neutralize the
PFA. The cells were permeabilized with 0.5% NP-40/PBS for 5’. Blocking solution was
added for 1 hr (10% NHS, 0.3% carragenin, 0.5% tritonX100 in 50 mM TBS) at room
temperature, followed by incubation with a rabbit polyclonal anti-pC/EBPb (Thr 188),
diluted 1:500 (cell signaling) in 1% NHS, 0.3% carragenin, 0.5% TritonX100 50 mM
TBS, ON at 4
 oC. Immunostainings were visualized using a secondary antibody
conjugated to Texas Red dye (Jackson lab) diluted 1:200 in TBS. The slides were
mounted with Vectashield mounting medium containing DAPI (Vector H2000).
4.7 Generation and genotyping of mice
For the generation of mGif/TIEG1 mutant mice, two clones derived from each construct,
null allele and conditional allele, were injected into C57BL/6 blastocysts and the
resulting chimeras were bred for germline transmission. Agouti animals were genotyped,
in order to distinguish the heterozygous from wild-type animals, using the southern blot
analysis  as described for the ES cells screening.
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